,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2018,protein catabolic process (GO:0030163),2/81,0.0061270772239647,0.1090329379829391,0,0,18.6516643225504,95.03092806855284,PRKN;PGC
64,GO_Biological_Process_2018,mitochondrial membrane organization (GO:0007006),1/19,0.0272053167113753,0.1090329379829391,0,0,39.58928571428572,142.69335919589085,MAIP1
63,GO_Biological_Process_2018,mitochondrial calcium ion homeostasis (GO:0051560),1/19,0.0272053167113753,0.1090329379829391,0,0,39.58928571428572,142.69335919589085,MAIP1
62,GO_Biological_Process_2018,DNA methylation (GO:0006306),1/18,0.02579144685281,0.1090329379829391,0,0,41.92016806722689,153.33191684558912,ATF7IP
61,GO_Biological_Process_2018,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,0.02579144685281,0.1090329379829391,0,0,41.92016806722689,153.33191684558912,PRKN
60,GO_Biological_Process_2018,regulation of protein localization to membrane (GO:1905475),1/17,0.0243755931875056,0.1090329379829391,0,0,44.54241071428572,165.43821595589523,PRKN
59,GO_Biological_Process_2018,glycosphingolipid biosynthetic process (GO:0006688),1/17,0.0243755931875056,0.1090329379829391,0,0,44.54241071428572,165.43821595589523,LARGE1
58,GO_Biological_Process_2018,protein mannosylation (GO:0035268),1/17,0.0243755931875056,0.1090329379829391,0,0,44.54241071428572,165.43821595589523,LARGE1
57,GO_Biological_Process_2018,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,0.0243755931875056,0.1090329379829391,0,0,44.54241071428572,165.43821595589523,PRKN
65,GO_Biological_Process_2018,regulation of mitochondrial fission (GO:0090140),1/19,0.0272053167113753,0.1090329379829391,0,0,39.58928571428572,142.69335919589085,PRKN
56,GO_Biological_Process_2018,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),2/163,0.0232066044071455,0.1090329379829391,0,0,9.114331723027377,34.30013198622245,EDAR;PRKN
54,GO_Biological_Process_2018,regulation of dopamine secretion (GO:0014059),1/16,0.0229577530466617,0.1090329379829391,0,0,47.51428571428571,179.32364557493287,PRKN
53,GO_Biological_Process_2018,DNA alkylation (GO:0006305),1/16,0.0229577530466617,0.1090329379829391,0,0,47.51428571428571,179.32364557493287,ATF7IP
52,GO_Biological_Process_2018,regulation of exosomal secretion (GO:1903541),1/16,0.0229577530466617,0.1090329379829391,0,0,47.51428571428571,179.32364557493287,PRKN
51,GO_Biological_Process_2018,DNA methylation or demethylation (GO:0044728),1/16,0.0229577530466617,0.1090329379829391,0,0,47.51428571428571,179.32364557493287,ATF7IP
50,GO_Biological_Process_2018,negative regulation of signal transduction by p53 class mediator (GO:1901797),1/15,0.0215379237658092,0.1090329379829391,0,0,50.910714285714285,195.39226686727991,PRKN
49,GO_Biological_Process_2018,negative regulation of insulin secretion (GO:0046676),1/15,0.0215379237658092,0.1090329379829391,0,0,50.910714285714285,195.39226686727991,PRKN
48,GO_Biological_Process_2018,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/15,0.0215379237658092,0.1090329379829391,0,0,50.910714285714285,195.39226686727991,PRKN
46,GO_Biological_Process_2018,N-acetylglucosamine metabolic process (GO:0006044),1/14,0.020116102664845,0.1090329379829391,0,0,54.82967032967033,214.17755847607225,LARGE1
55,GO_Biological_Process_2018,negative regulation of peptide hormone secretion (GO:0090278),1/16,0.0229577530466617,0.1090329379829391,0,0,47.51428571428571,179.32364557493287,PRKN
45,GO_Biological_Process_2018,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/14,0.020116102664845,0.1090329379829391,0,0,54.82967032967033,214.17755847607225,PRKN
66,GO_Biological_Process_2018,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,0.0286172054274548,0.1090329379829391,0,0,37.50375939849624,133.2788782141628,PRKN
68,GO_Biological_Process_2018,regulation of transport (GO:0051049),1/20,0.0286172054274548,0.1090329379829391,0,0,37.50375939849624,133.2788782141628,PRKN
86,GO_Biological_Process_2018,regulation of actin filament bundle assembly (GO:0032231),1/24,0.0342450021823671,0.1090329379829391,0,0,30.975155279503102,104.51682262493934,PRKN
85,GO_Biological_Process_2018,negative regulation of oxidative stress-induced cell death (GO:1903202),1/24,0.0342450021823671,0.1090329379829391,0,0,30.975155279503102,104.51682262493934,PRKN
84,GO_Biological_Process_2018,negative regulation of cytoskeleton organization (GO:0051494),1/24,0.0342450021823671,0.1090329379829391,0,0,30.975155279503102,104.51682262493934,PRKN
83,GO_Biological_Process_2018,transition metal ion homeostasis (GO:0055076),1/24,0.0342450021823671,0.1090329379829391,0,0,30.975155279503102,104.51682262493934,PRKN
82,GO_Biological_Process_2018,macromolecule modification (GO:0043412),1/24,0.0342450021823671,0.1090329379829391,0,0,30.975155279503102,104.51682262493934,LRPPRC
81,GO_Biological_Process_2018,cellular response to ammonium ion (GO:0071242),1/23,0.0328410113902878,0.1090329379829391,0,0,32.38474025974026,110.62877274373584,PRKN
80,GO_Biological_Process_2018,divalent inorganic cation homeostasis (GO:0072507),1/23,0.0328410113902878,0.1090329379829391,0,0,32.38474025974026,110.62877274373584,PRKN
79,GO_Biological_Process_2018,cellular response to catecholamine stimulus (GO:0071870),1/23,0.0328410113902878,0.1090329379829391,0,0,32.38474025974026,110.62877274373584,PRKN
67,GO_Biological_Process_2018,negative regulation of actin filament bundle assembly (GO:0032232),1/20,0.0286172054274548,0.1090329379829391,0,0,37.50375939849624,133.2788782141628,PRKN
78,GO_Biological_Process_2018,activation of phospholipase C activity (GO:0007202),1/22,0.031435050111481,0.1090329379829391,0,0,33.92857142857143,117.38714910240454,ITK
76,GO_Biological_Process_2018,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/22,0.031435050111481,0.1090329379829391,0,0,33.92857142857143,117.38714910240454,PRKN
75,GO_Biological_Process_2018,cytosolic calcium ion transport (GO:0060401),1/22,0.031435050111481,0.1090329379829391,0,0,33.92857142857143,117.38714910240454,MAIP1
74,GO_Biological_Process_2018,regulation of catecholamine secretion (GO:0050433),1/22,0.031435050111481,0.1090329379829391,0,0,33.92857142857143,117.38714910240454,PRKN
73,GO_Biological_Process_2018,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,0.031435050111481,0.1090329379829391,0,0,33.92857142857143,117.38714910240454,PRKN
72,GO_Biological_Process_2018,mitochondrial fission (GO:0000266),1/21,0.0300271156735161,0.1090329379829391,0,0,35.62678571428572,124.89519987020886,PRKN
71,GO_Biological_Process_2018,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),1/21,0.0300271156735161,0.1090329379829391,0,0,35.62678571428572,124.89519987020886,MAIP1
70,GO_Biological_Process_2018,mitochondrial calcium ion transmembrane transport (GO:0006851),1/21,0.0300271156735161,0.1090329379829391,0,0,35.62678571428572,124.89519987020886,MAIP1
69,GO_Biological_Process_2018,dopamine metabolic process (GO:0042417),1/20,0.0286172054274548,0.1090329379829391,0,0,37.50375939849624,133.2788782141628,PRKN
77,GO_Biological_Process_2018,cellular response to unfolded protein (GO:0034620),1/22,0.031435050111481,0.1090329379829391,0,0,33.92857142857143,117.38714910240454,PRKN
44,GO_Biological_Process_2018,regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,0.020116102664845,0.1090329379829391,0,0,54.82967032967033,214.17755847607225,PRKN
47,GO_Biological_Process_2018,catecholamine metabolic process (GO:0006584),1/15,0.0215379237658092,0.1090329379829391,0,0,50.910714285714285,195.39226686727991,PRKN
42,GO_Biological_Process_2018,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,0.020116102664845,0.1090329379829391,0,0,54.82967032967033,214.17755847607225,PRKN
19,GO_Biological_Process_2018,negative regulation of exocytosis (GO:0045920),1/8,0.0115431985365684,0.1090329379829391,0,0,101.85714285714286,454.4518266085444,PRKN
43,GO_Biological_Process_2018,positive regulation of mitochondrial fission (GO:0090141),1/14,0.020116102664845,0.1090329379829391,0,0,54.82967032967033,214.17755847607225,PRKN
17,GO_Biological_Process_2018,protein K6-linked ubiquitination (GO:0085020),1/8,0.0115431985365684,0.1090329379829391,0,0,101.85714285714286,454.4518266085444,PRKN
16,GO_Biological_Process_2018,regulation of lipid transport (GO:0032368),1/8,0.0115431985365684,0.1090329379829391,0,0,101.85714285714286,454.4518266085444,PRKN
15,GO_Biological_Process_2018,regulation of establishment of protein localization to mitochondrion (GO:1903747),1/8,0.0115431985365684,0.1090329379829391,0,0,101.85714285714286,454.4518266085444,PRKN
14,GO_Biological_Process_2018,protein insertion into mitochondrial membrane (GO:0051204),1/8,0.0115431985365684,0.1090329379829391,0,0,101.85714285714286,454.4518266085444,MAIP1
13,GO_Biological_Process_2018,regulation of mitochondrial fusion (GO:0010635),1/7,0.0101073601190722,0.1090329379829391,0,0,118.83928571428572,546.0060757050519,PRKN
12,GO_Biological_Process_2018,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/7,0.0101073601190722,0.1090329379829391,0,0,118.83928571428572,546.0060757050519,PRKN
11,GO_Biological_Process_2018,positive regulation of autophagy of mitochondrion (GO:1903599),1/7,0.0101073601190722,0.1090329379829391,0,0,118.83928571428572,546.0060757050519,PRKN
10,GO_Biological_Process_2018,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,PRKN
9,GO_Biological_Process_2018,regulation of protein targeting (GO:1903533),1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,PRKN
8,GO_Biological_Process_2018,regulation of cellular response to oxidative stress (GO:1900407),1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,PRKN
7,GO_Biological_Process_2018,regulation of glucokinase activity (GO:0033131),1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,PRKN
6,GO_Biological_Process_2018,response to manganese ion (GO:0010042),1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,PRKN
5,GO_Biological_Process_2018,positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,PRKN
4,GO_Biological_Process_2018,regulation of dopamine metabolic process (GO:0042053),1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,PRKN
3,GO_Biological_Process_2018,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,PRKN
2,GO_Biological_Process_2018,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,0.0086695086687213,0.1090329379829391,0,0,142.61428571428573,677.1245223853919,LRPPRC
1,GO_Biological_Process_2018,regulation of JNK cascade (GO:0046328),2/90,0.007513009734906,0.1090329379829391,0,0,16.736531986531986,81.8603717667472,EDAR;PRKN
20,GO_Biological_Process_2018,regulation of oxidative stress-induced cell death (GO:1903201),1/9,0.0129770265246845,0.1090329379829391,0,0,89.12053571428571,387.1908225092229,PRKN
21,GO_Biological_Process_2018,response to dopamine (GO:1903350),1/9,0.0129770265246845,0.1090329379829391,0,0,89.12053571428571,387.1908225092229,PRKN
18,GO_Biological_Process_2018,regulation of response to oxidative stress (GO:1902882),1/8,0.0115431985365684,0.1090329379829391,0,0,101.85714285714286,454.4518266085444,PRKN
23,GO_Biological_Process_2018,cellular response to dopamine (GO:1903351),1/9,0.0129770265246845,0.1090329379829391,0,0,89.12053571428571,387.1908225092229,PRKN
41,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/396,0.0192280031547828,0.1090329379829391,0,0,5.748091603053435,22.712937682085588,PTPRT;ITK;FRS3
40,GO_Biological_Process_2018,regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,0.0186922870807393,0.1090329379829391,0,0,59.40178571428572,236.3979776770167,PRKN
39,GO_Biological_Process_2018,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/13,0.0186922870807393,0.1090329379829391,0,0,59.40178571428572,236.3979776770167,ATF7IP
38,GO_Biological_Process_2018,glucosamine-containing compound metabolic process (GO:1901071),1/13,0.0186922870807393,0.1090329379829391,0,0,59.40178571428572,236.3979776770167,LARGE1
22,GO_Biological_Process_2018,mitochondrial calcium uptake (GO:0036444),1/9,0.0129770265246845,0.1090329379829391,0,0,89.12053571428571,387.1908225092229,MAIP1
36,GO_Biological_Process_2018,modulation by virus of host process (GO:0019054),1/13,0.0186922870807393,0.1090329379829391,0,0,59.40178571428572,236.3979776770167,PRKN
35,GO_Biological_Process_2018,mitochondrion transport along microtubule (GO:0047497),1/12,0.0172664743371053,0.1090329379829391,0,0,64.8051948051948,263.043544162992,LRPPRC
34,GO_Biological_Process_2018,protein insertion into membrane (GO:0051205),1/12,0.0172664743371053,0.1090329379829391,0,0,64.8051948051948,263.043544162992,MAIP1
33,GO_Biological_Process_2018,negative regulation of oxidoreductase activity (GO:0051354),1/12,0.0172664743371053,0.1090329379829391,0,0,64.8051948051948,263.043544162992,PRKN
37,GO_Biological_Process_2018,regulation of synaptic vesicle transport (GO:1902803),1/13,0.0186922870807393,0.1090329379829391,0,0,59.40178571428572,236.3979776770167,PRKN
31,GO_Biological_Process_2018,protein O-linked mannosylation (GO:0035269),1/11,0.0158386617716755,0.1090329379829391,0,0,71.28928571428571,295.5155744703354,LARGE1
32,GO_Biological_Process_2018,regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898),1/11,0.0158386617716755,0.1090329379829391,0,0,71.28928571428571,295.5155744703354,ATF7IP
25,GO_Biological_Process_2018,mitochondrial respiratory chain complex III biogenesis (GO:0097033),1/10,0.0144088467211374,0.1090329379829391,0,0,79.21428571428571,335.8616722924233,MAIP1
26,GO_Biological_Process_2018,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,0.0144088467211374,0.1090329379829391,0,0,79.21428571428571,335.8616722924233,PRKN
24,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),2/120,0.0130398000134282,0.1090329379829391,0,0,12.462649089767734,54.08476965990156,PTPRT;ITK
28,GO_Biological_Process_2018,positive regulation of cytoplasmic transport (GO:1903651),1/10,0.0144088467211374,0.1090329379829391,0,0,79.21428571428571,335.8616722924233,PRKN
29,GO_Biological_Process_2018,negative regulation by host of viral process (GO:0044793),1/10,0.0144088467211374,0.1090329379829391,0,0,79.21428571428571,335.8616722924233,PRKN
30,GO_Biological_Process_2018,modulation by host of viral genome replication (GO:0044827),1/11,0.0158386617716755,0.1090329379829391,0,0,71.28928571428571,295.5155744703354,PRKN
27,GO_Biological_Process_2018,protein localization to mitochondrion (GO:0070585),1/10,0.0144088467211374,0.1090329379829391,0,0,79.21428571428571,335.8616722924233,MAIP1
87,GO_Biological_Process_2018,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),2/204,0.035093724013126,0.1097136218043574,0,0,7.24935826916025,24.28341438773168,EDAR;PRKN
88,GO_Biological_Process_2018,female gamete generation (GO:0007292),1/25,0.0356470251349897,0.1097136218043574,0,0,29.683035714285715,98.96590013795104,MCM9
89,GO_Biological_Process_2018,regulation of glucose metabolic process (GO:0010906),1/25,0.0356470251349897,0.1097136218043574,0,0,29.683035714285715,98.96590013795104,PRKN
94,GO_Biological_Process_2018,protein K11-linked ubiquitination (GO:0070979),1/28,0.0398413134963124,0.1149587899841516,0,0,26.38095238095238,85.02187553087816,PRKN
90,GO_Biological_Process_2018,regulation of autophagy of mitochondrion (GO:1903146),1/27,0.0384451781473962,0.1149587899841516,0,0,27.396978021978025,89.27365552728025,PRKN
91,GO_Biological_Process_2018,cellular response to topologically incorrect protein (GO:0035967),1/27,0.0384451781473962,0.1149587899841516,0,0,27.396978021978025,89.27365552728025,PRKN
92,GO_Biological_Process_2018,organelle fission (GO:0048285),1/28,0.0398413134963124,0.1149587899841516,0,0,26.38095238095238,85.02187553087816,PRKN
93,GO_Biological_Process_2018,calcium ion import (GO:0070509),1/28,0.0398413134963124,0.1149587899841516,0,0,26.38095238095238,85.02187553087816,MAIP1
95,GO_Biological_Process_2018,negative regulation of JNK cascade (GO:0046329),1/28,0.0398413134963124,0.1149587899841516,0,0,26.38095238095238,85.02187553087816,PRKN
97,GO_Biological_Process_2018,skeletal muscle organ development (GO:0060538),1/29,0.0412354916064529,0.1165533793366066,0,0,25.4375,81.10634814419134,LARGE1
96,GO_Biological_Process_2018,carbohydrate derivative biosynthetic process (GO:1901137),1/29,0.0412354916064529,0.1165533793366066,0,0,25.4375,81.10634814419134,LARGE1
98,GO_Biological_Process_2018,positive regulation of phospholipase C activity (GO:0010863),1/30,0.0426277151111442,0.1180787708578695,0,0,24.55911330049261,77.49015815040234,ITK
99,GO_Biological_Process_2018,negative regulation of stress-activated MAPK cascade (GO:0032873),1/30,0.0426277151111442,0.1180787708578695,0,0,24.55911330049261,77.49015815040234,PRKN
100,GO_Biological_Process_2018,protein destabilization (GO:0031648),1/31,0.044017986659766,0.1183784689782059,0,0,23.739285714285717,74.14151494993529,PRKN
101,GO_Biological_Process_2018,organelle transport along microtubule (GO:0072384),1/31,0.044017986659766,0.1183784689782059,0,0,23.739285714285717,74.14151494993529,LRPPRC
102,GO_Biological_Process_2018,zinc ion homeostasis (GO:0055069),1/31,0.044017986659766,0.1183784689782059,0,0,23.739285714285717,74.14151494993529,PRKN
103,GO_Biological_Process_2018,mitochondrial transmembrane transport (GO:1990542),1/32,0.0454063088797545,0.1209379573047309,0,0,22.972350230414747,71.03290112478346,MAIP1
105,GO_Biological_Process_2018,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/33,0.0467926844046366,0.1222789960385317,0,0,22.253348214285715,68.14038432553451,PRKN
104,GO_Biological_Process_2018,negative regulation of mitochondrion organization (GO:0010823),1/33,0.0467926844046366,0.1222789960385317,0,0,22.253348214285715,68.14038432553451,PRKN
107,GO_Biological_Process_2018,negative regulation of cellular metabolic process (GO:0031324),1/34,0.0481771158578003,0.1224317531432175,0,0,21.57792207792208,65.4430572478459,PRKN
108,GO_Biological_Process_2018,positive regulation of DNA binding (GO:0043388),1/34,0.0481771158578003,0.1224317531432175,0,0,21.57792207792208,65.4430572478459,PRKN
106,GO_Biological_Process_2018,macromolecule catabolic process (GO:0009057),1/34,0.0481771158578003,0.1224317531432175,0,0,21.57792207792208,65.4430572478459,PGC
109,GO_Biological_Process_2018,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/35,0.049559605875515,0.1248000984319787,0,0,20.942226890756302,62.92257878831688,CDC25A
110,GO_Biological_Process_2018,inner mitochondrial membrane organization (GO:0007007),1/36,0.0509401570739593,0.1271209325178986,0,0,20.34285714285714,60.56279579598777,MAIP1
112,GO_Biological_Process_2018,protein monoubiquitination (GO:0006513),1/37,0.0523187720746184,0.1282504412802592,0,0,19.776785714285715,58.34942939474461,PRKN
111,GO_Biological_Process_2018,protein K63-linked ubiquitination (GO:0070534),1/37,0.0523187720746184,0.1282504412802592,0,0,19.776785714285715,58.34942939474461,PRKN
120,GO_Biological_Process_2018,regulation of intracellular transport (GO:0032386),1/40,0.0564430260228561,0.1292125471762905,0,0,18.25274725274725,52.46795162162656,PRKN
119,GO_Biological_Process_2018,negative regulation of transport (GO:0051051),1/40,0.0564430260228561,0.1292125471762905,0,0,18.25274725274725,52.46795162162656,PRKN
118,GO_Biological_Process_2018,autophagy of mitochondrion (GO:0000422),1/40,0.0564430260228561,0.1292125471762905,0,0,18.25274725274725,52.46795162162656,PRKN
117,GO_Biological_Process_2018,regulation of release of cytochrome c from mitochondria (GO:0090199),1/40,0.0564430260228561,0.1292125471762905,0,0,18.25274725274725,52.46795162162656,PRKN
114,GO_Biological_Process_2018,mitochondrion disassembly (GO:0061726),1/38,0.0536954534974879,0.1292125471762905,0,0,19.24131274131274,56.26981345523857,PRKN
115,GO_Biological_Process_2018,protein modification by small protein removal (GO:0070646),2/261,0.0546806411291054,0.1292125471762905,0,0,5.637637637637638,16.384359252266364,PRKN;CDC25A
113,GO_Biological_Process_2018,protein deubiquitination (GO:0016579),2/257,0.0532016420520259,0.1292125471762905,0,0,5.72723311546841,16.80178916498588,PRKN;CDC25A
116,GO_Biological_Process_2018,regulation of proteasomal protein catabolic process (GO:0061136),1/39,0.055070203944055,0.1292125471762905,0,0,18.73402255639098,54.31267540736575,PRKN
121,GO_Biological_Process_2018,regulation of cellular metabolic process (GO:0031323),1/41,0.0578139223569284,0.1312660368267966,0,0,17.795535714285716,50.72663120626347,PRKN
122,GO_Biological_Process_2018,glycolipid biosynthetic process (GO:0009247),1/42,0.0591828955366752,0.1322069521262826,0,0,17.360627177700348,49.080623277270966,LARGE1
123,GO_Biological_Process_2018,negative regulation of protein secretion (GO:0050709),1/42,0.0591828955366752,0.1322069521262826,0,0,17.360627177700348,49.080623277270966,PRKN
124,GO_Biological_Process_2018,response to unfolded protein (GO:0006986),1/43,0.0605499481664255,0.1341786851367989,0,0,16.946428571428573,47.52264366272739,PRKN
125,GO_Biological_Process_2018,peptidyl-tyrosine autophosphorylation (GO:0038083),1/45,0.0632783021573496,0.1380164543116997,0,0,16.17451298701299,44.64509756246689,ITK
126,GO_Biological_Process_2018,protein polymerization (GO:0051258),1/45,0.0632783021573496,0.1380164543116997,0,0,16.17451298701299,44.64509756246689,PRKN
341,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,PRKN
337,GO_Biological_Process_2017b,FasL biosynthetic process (GO:0045210),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LARGE1
340,GO_Biological_Process_2017b,negative regulation of actin filament bundle assembly (GO:0032232),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,PRKN
339,GO_Biological_Process_2017b,regulation of phospholipid transport (GO:2001138),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,PRKN
338,GO_Biological_Process_2017b,CD86 biosynthetic process (GO:0035781),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LARGE1
336,GO_Biological_Process_2017b,cellular response to manganese ion (GO:0071287),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,PRKN
360,GO_Biological_Process_2017b,isogloboside biosynthetic process (GO:1990387),1/8,0.0115431985365684,0.1403198996607425,0,0,101.85714285714286,454.4518266085444,LARGE1
334,GO_Biological_Process_2017b,CD80 biosynthetic process (GO:0035780),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LARGE1
333,GO_Biological_Process_2017b,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,PRKN
332,GO_Biological_Process_2017b,dendritic transport of mitochondrion (GO:0098939),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LRPPRC
331,GO_Biological_Process_2017b,CD4 biosynthetic process (GO:0045222),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LARGE1
330,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress (GO:1900407),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,PRKN
329,GO_Biological_Process_2017b,vascular endothelial growth factor signaling pathway (GO:0038084),2/90,0.007513009734906,0.1403198996607425,0,0,16.736531986531986,81.8603717667472,PTPRT;ITK
342,GO_Biological_Process_2017b,RNA methylation (GO:0001510),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LRPPRC
335,GO_Biological_Process_2017b,mannoprotein biosynthetic process (GO:0006057),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LARGE1
343,GO_Biological_Process_2017b,cell wall glycoprotein biosynthetic process (GO:0031506),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LARGE1
358,GO_Biological_Process_2017b,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),2/112,0.0114336448876098,0.1403198996607425,0,0,13.374410774410777,59.79959810374703,PTPRT;ITK
345,GO_Biological_Process_2017b,mitochondrial unfolded protein response (GO:0034514),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,PRKN
359,GO_Biological_Process_2017b,elastin biosynthetic process (GO:0051542),1/8,0.0115431985365684,0.1403198996607425,0,0,101.85714285714286,454.4518266085444,LARGE1
328,GO_Biological_Process_2017b,platelet-derived growth factor receptor signaling pathway (GO:0048008),2/85,0.0067270100762715,0.1403198996607425,0,0,17.74921909861669,88.77492913598229,PTPRT;ITK
357,GO_Biological_Process_2017b,diaphragm development (GO:0060539),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,LARGE1
356,GO_Biological_Process_2017b,negative regulation of primary amine oxidase activity (GO:1902283),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
355,GO_Biological_Process_2017b,dopamine metabolic process (GO:0042417),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
354,GO_Biological_Process_2017b,regulation of removal of superoxide radicals (GO:2000121),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
344,GO_Biological_Process_2017b,CD24 biosynthetic process (GO:0035724),1/6,0.0086695086687213,0.1403198996607425,0,0,142.61428571428573,677.1245223853919,LARGE1
353,GO_Biological_Process_2017b,myoblast migration involved in skeletal muscle regeneration (GO:0014839),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,LARGE1
351,GO_Biological_Process_2017b,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
350,GO_Biological_Process_2017b,positive regulation of mitochondrial fusion (GO:0010636),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
349,GO_Biological_Process_2017b,regulation of fatty acid transport (GO:2000191),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
348,GO_Biological_Process_2017b,negative regulation of exosomal secretion (GO:1903542),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
347,GO_Biological_Process_2017b,myotube differentiation involved in skeletal muscle regeneration (GO:0014908),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,LARGE1
346,GO_Biological_Process_2017b,regulation of protein import into mitochondrial outer membrane (GO:1903636),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
352,GO_Biological_Process_2017b,negative regulation of mitochondrial fusion (GO:0010637),1/7,0.0101073601190722,0.1403198996607425,0,0,118.83928571428572,546.0060757050519,PRKN
327,GO_Biological_Process_2017b,hepatocyte growth factor receptor signaling pathway (GO:0048012),2/83,0.0064238145177717,0.1403198996607425,0,0,18.189300411522638,91.81491702989103,PTPRT;ITK
436,GO_Biological_Process_2017b,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045899),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,ATF7IP
325,GO_Biological_Process_2017b,neurotrophin TRK receptor signaling pathway (GO:0048011),2/80,0.0059811421098148,0.1403198996607425,0,0,18.891737891737893,96.709521784955,PTPRT;ITK
455,GO_Biological_Process_2017b,regulation of ubiquitin-protein transferase activity (GO:0051438),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,PRKN
454,GO_Biological_Process_2017b,maintenance of unfolded protein involved in ERAD pathway (GO:1904378),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,PRKN
453,GO_Biological_Process_2017b,positive regulation of DNA replication origin binding (GO:1902597),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,PRKN
452,GO_Biological_Process_2017b,regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,PRKN
451,GO_Biological_Process_2017b,regulation of mitochondrial fission (GO:0090140),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,PRKN
450,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0072335),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,PRKN
449,GO_Biological_Process_2017b,positive regulation of glucose metabolic process (GO:0010907),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,PRKN
448,GO_Biological_Process_2017b,positive regulation of NF-kappaB import into nucleus (GO:0042346),2/170,0.0250924043259784,0.1403198996607425,0,0,8.731481481481481,32.17716907142676,EDAR;PRKN
447,GO_Biological_Process_2017b,positive regulation of telomeric DNA binding (GO:1904744),1/17,0.0243755931875056,0.1403198996607425,0,0,44.54241071428572,165.43821595589523,PRKN
446,GO_Biological_Process_2017b,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/17,0.0243755931875056,0.1403198996607425,0,0,44.54241071428572,165.43821595589523,PRKN
445,GO_Biological_Process_2017b,glycoprotein biosynthetic process (GO:0009101),1/17,0.0243755931875056,0.1403198996607425,0,0,44.54241071428572,165.43821595589523,LARGE1
444,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/17,0.0243755931875056,0.1403198996607425,0,0,44.54241071428572,165.43821595589523,PRKN
443,GO_Biological_Process_2017b,regulation of hydrogen peroxide metabolic process (GO:0010310),1/17,0.0243755931875056,0.1403198996607425,0,0,44.54241071428572,165.43821595589523,PRKN
442,GO_Biological_Process_2017b,protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379),1/17,0.0243755931875056,0.1403198996607425,0,0,44.54241071428572,165.43821595589523,PRKN
441,GO_Biological_Process_2017b,cellular zinc ion homeostasis (GO:0006882),1/17,0.0243755931875056,0.1403198996607425,0,0,44.54241071428572,165.43821595589523,PRKN
440,GO_Biological_Process_2017b,DNA methylation involved in embryo development (GO:0043045),1/17,0.0243755931875056,0.1403198996607425,0,0,44.54241071428572,165.43821595589523,ATF7IP
439,GO_Biological_Process_2017b,Kit signaling pathway (GO:0038109),2/163,0.0232066044071455,0.1403198996607425,0,0,9.114331723027377,34.30013198622245,PTPRT;ITK
324,GO_Biological_Process_2017b,growth hormone receptor signaling pathway (GO:0060396),2/80,0.0059811421098148,0.1403198996607425,0,0,18.891737891737893,96.709521784955,PTPRT;ITK
323,GO_Biological_Process_2017b,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/77,0.0055531272095954,0.1403198996607425,0,0,19.65037037037037,102.05211653662693,PTPRT;ITK
322,GO_Biological_Process_2017b,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),2/76,0.0054137347517828,0.1403198996607425,0,0,19.91691691691692,103.9427263100929,PTPRT;ITK
321,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),2/76,0.0054137347517828,0.1403198996607425,0,0,19.91691691691692,103.9427263100929,PTPRT;ITK
320,GO_Biological_Process_2017b,brain-derived neurotrophic factor receptor signaling pathway (GO:0031547),2/75,0.0052759897537052,0.1403198996607425,0,0,20.190766108574326,105.89226955569332,PTPRT;ITK
319,GO_Biological_Process_2017b,glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),2/74,0.0051398969523133,0.1403198996607425,0,0,20.47222222222222,107.90339713070315,PTPRT;ITK
326,GO_Biological_Process_2017b,insulin-like growth factor receptor signaling pathway (GO:0048009),2/82,0.0062746362532476,0.1403198996607425,0,0,18.41759259259259,93.40002789897537,PTPRT;ITK
318,GO_Biological_Process_2017b,Tie signaling pathway (GO:0048014),2/74,0.0051398969523133,0.1403198996607425,0,0,20.47222222222222,107.90339713070315,PTPRT;ITK
316,GO_Biological_Process_2017b,proteasomal protein catabolic process (GO:0010498),2/59,0.0033000187698343,0.1403198996607425,0,0,25.87914230019493,147.86894518699629,PRKN;PGC
315,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway (GO:0008543),3/166,0.0017508698683985,0.1403198996607425,0,0,14.021708352996695,89.00479252153153,PTPRT;ITK;FRS3
434,GO_Biological_Process_2017b,positive regulation of recombination hotspot binding (GO:1903643),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
435,GO_Biological_Process_2017b,female germ-line cyst encapsulation (GO:0048139),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,MCM9
437,GO_Biological_Process_2017b,regulation of protein targeting to mitochondrion (GO:1903214),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
438,GO_Biological_Process_2017b,positive regulation of mitochondrial calcium ion concentration (GO:0051561),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,MAIP1
317,GO_Biological_Process_2017b,sevenless signaling pathway (GO:0045500),2/72,0.0048726869346467,0.1403198996607425,0,0,21.05925925925926,112.12180780429958,PTPRT;ITK
361,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384),1/8,0.0115431985365684,0.1403198996607425,0,0,101.85714285714286,454.4518266085444,PRKN
425,GO_Biological_Process_2017b,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),2/162,0.0229422519163454,0.1403198996607425,0,0,9.17175925925926,34.62132761848302,EDAR;PRKN
363,GO_Biological_Process_2017b,regulation of oxidative stress-induced cell death (GO:1903201),1/9,0.0129770265246845,0.1403198996607425,0,0,89.12053571428571,387.1908225092229,PRKN
413,GO_Biological_Process_2017b,regulation of nitric oxide metabolic process (GO:0080164),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
412,GO_Biological_Process_2017b,regulation of dopamine secretion (GO:0014059),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
411,GO_Biological_Process_2017b,negative regulation of mitochondrion organization (GO:0010823),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
410,GO_Biological_Process_2017b,cellular response to dopamine (GO:1903351),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
409,GO_Biological_Process_2017b,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,MAIP1
408,GO_Biological_Process_2017b,negative regulation of removal of superoxide radicals (GO:1904832),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
414,GO_Biological_Process_2017b,regulation of histone ubiquitination (GO:0033182),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
407,GO_Biological_Process_2017b,dopamine catabolic process (GO:0042420),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
405,GO_Biological_Process_2017b,positive regulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085033),2/148,0.0193768839947435,0.1403198996607425,0,0,10.058346017250129,39.66684239897434,EDAR;PRKN
404,GO_Biological_Process_2017b,regulation of protein autoubiquitination (GO:1902498),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
403,GO_Biological_Process_2017b,positive regulation of ERAD pathway (GO:1904294),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
402,GO_Biological_Process_2017b,regulation of release of cytochrome c from mitochondria (GO:0090199),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
401,GO_Biological_Process_2017b,rhodopsin catabolic process (GO:0046155),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
400,GO_Biological_Process_2017b,mitochondrial respiratory chain complex III assembly (GO:0034551),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,MAIP1
406,GO_Biological_Process_2017b,regulation of mitochondrial fusion (GO:0010635),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
399,GO_Biological_Process_2017b,PSII associated light-harvesting complex II catabolic process (GO:0010304),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
415,GO_Biological_Process_2017b,regulation of superoxide metabolic process (GO:0090322),1/14,0.020116102664845,0.1403198996607425,0,0,54.82967032967033,214.17755847607225,PRKN
417,GO_Biological_Process_2017b,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/15,0.0215379237658092,0.1403198996607425,0,0,50.910714285714285,195.39226686727991,PRKN
431,GO_Biological_Process_2017b,negative regulation of dopamine secretion (GO:0033602),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
430,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide metabolic process (GO:0010727),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
429,GO_Biological_Process_2017b,positive regulation of triplex DNA binding (GO:1905498),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
428,GO_Biological_Process_2017b,female gamete generation (GO:0007292),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,MCM9
427,GO_Biological_Process_2017b,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
426,GO_Biological_Process_2017b,positive regulation of G-quadruplex DNA binding (GO:1905495),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
416,GO_Biological_Process_2017b,ephrin receptor signaling pathway (GO:0048013),2/151,0.0201193223078025,0.1403198996607425,0,0,9.854337559035546,38.4917778050494,PTPRT;ITK
456,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,PRKN
423,GO_Biological_Process_2017b,DNA methylation on cytosine (GO:0032776),1/15,0.0215379237658092,0.1403198996607425,0,0,50.910714285714285,195.39226686727991,ATF7IP
422,GO_Biological_Process_2017b,DNA methylation on adenine (GO:0032775),1/15,0.0215379237658092,0.1403198996607425,0,0,50.910714285714285,195.39226686727991,ATF7IP
421,GO_Biological_Process_2017b,positive regulation of protein localization to plasma membrane (GO:1903078),1/15,0.0215379237658092,0.1403198996607425,0,0,50.910714285714285,195.39226686727991,PRKN
420,GO_Biological_Process_2017b,protein catabolic process in the vacuole (GO:0007039),1/15,0.0215379237658092,0.1403198996607425,0,0,50.910714285714285,195.39226686727991,PRKN
419,GO_Biological_Process_2017b,regulation of gluconeogenesis (GO:0006111),1/15,0.0215379237658092,0.1403198996607425,0,0,50.910714285714285,195.39226686727991,PRKN
418,GO_Biological_Process_2017b,regulation of mitochondrion organization (GO:0010821),1/15,0.0215379237658092,0.1403198996607425,0,0,50.910714285714285,195.39226686727991,PRKN
424,GO_Biological_Process_2017b,DNA methylation (GO:0006306),1/15,0.0215379237658092,0.1403198996607425,0,0,50.910714285714285,195.39226686727991,ATF7IP
362,GO_Biological_Process_2017b,positive regulation of synaptic vesicle transport (GO:1902805),1/8,0.0115431985365684,0.1403198996607425,0,0,101.85714285714286,454.4518266085444,PRKN
398,GO_Biological_Process_2017b,GSI anchor biosynthetic process (GO:0042082),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,LARGE1
396,GO_Biological_Process_2017b,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
377,GO_Biological_Process_2017b,regulation of UDP-glucose catabolic process (GO:0010904),1/11,0.0158386617716755,0.1403198996607425,0,0,71.28928571428571,295.5155744703354,PRKN
376,GO_Biological_Process_2017b,myoblast differentiation involved in skeletal muscle regeneration (GO:0014835),1/11,0.0158386617716755,0.1403198996607425,0,0,71.28928571428571,295.5155744703354,LARGE1
375,GO_Biological_Process_2017b,primary miRNA modification (GO:1990729),1/11,0.0158386617716755,0.1403198996607425,0,0,71.28928571428571,295.5155744703354,LRPPRC
374,GO_Biological_Process_2017b,negative regulation of superoxide anion generation (GO:0032929),1/11,0.0158386617716755,0.1403198996607425,0,0,71.28928571428571,295.5155744703354,PRKN
373,GO_Biological_Process_2017b,regulation of glucokinase activity (GO:0033131),1/11,0.0158386617716755,0.1403198996607425,0,0,71.28928571428571,295.5155744703354,PRKN
372,GO_Biological_Process_2017b,mitochondrion transport along microtubule (GO:0047497),1/11,0.0158386617716755,0.1403198996607425,0,0,71.28928571428571,295.5155744703354,LRPPRC
378,GO_Biological_Process_2017b,regulation of glucose metabolic process (GO:0010906),1/11,0.0158386617716755,0.1403198996607425,0,0,71.28928571428571,295.5155744703354,PRKN
371,GO_Biological_Process_2017b,N-acetylglucosamine metabolic process (GO:0006044),1/10,0.0144088467211374,0.1403198996607425,0,0,79.21428571428571,335.8616722924233,LARGE1
369,GO_Biological_Process_2017b,negative regulation of mitochondrial calcium ion concentration (GO:0051562),1/10,0.0144088467211374,0.1403198996607425,0,0,79.21428571428571,335.8616722924233,MAIP1
368,GO_Biological_Process_2017b,negative regulation of nitric oxide metabolic process (GO:1904406),1/10,0.0144088467211374,0.1403198996607425,0,0,79.21428571428571,335.8616722924233,PRKN
367,GO_Biological_Process_2017b,N-acetylglucosamine biosynthetic process (GO:0006045),1/10,0.0144088467211374,0.1403198996607425,0,0,79.21428571428571,335.8616722924233,LARGE1
366,GO_Biological_Process_2017b,negative regulation of lipid transport (GO:0032369),1/9,0.0129770265246845,0.1403198996607425,0,0,89.12053571428571,387.1908225092229,PRKN
365,GO_Biological_Process_2017b,mitochondrial calcium uptake involved in negative regulation of presynaptic cytosolic calcium concentration (GO:1905743),1/9,0.0129770265246845,0.1403198996607425,0,0,89.12053571428571,387.1908225092229,MAIP1
364,GO_Biological_Process_2017b,globoside biosynthetic process (GO:0001576),1/9,0.0129770265246845,0.1403198996607425,0,0,89.12053571428571,387.1908225092229,LARGE1
370,GO_Biological_Process_2017b,N-acetylglucosamine catabolic process (GO:0006046),1/10,0.0144088467211374,0.1403198996607425,0,0,79.21428571428571,335.8616722924233,LARGE1
397,GO_Biological_Process_2017b,regulation of cristae formation (GO:1903850),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
379,GO_Biological_Process_2017b,vascular endothelial growth factor receptor signaling pathway (GO:0048010),2/133,0.0158465022518241,0.1403198996607425,0,0,11.218546791065876,46.49870544847218,PTPRT;ITK
381,GO_Biological_Process_2017b,regulation of glycogen metabolic process (GO:0070873),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
395,GO_Biological_Process_2017b,negative regulation of protein targeting to mitochondrion (GO:1903215),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
394,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process (GO:2000377),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
393,GO_Biological_Process_2017b,prosthetic group catabolic process (GO:0051190),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
392,GO_Biological_Process_2017b,histone catabolic process (GO:0036205),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
391,GO_Biological_Process_2017b,protein denaturation (GO:0030164),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
390,GO_Biological_Process_2017b,regulation of mitochondrial DNA metabolic process (GO:1901858),1/13,0.0186922870807393,0.1403198996607425,0,0,59.40178571428572,236.3979776770167,PRKN
380,GO_Biological_Process_2017b,regulation of protein ubiquitination (GO:0031396),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
389,GO_Biological_Process_2017b,regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
387,GO_Biological_Process_2017b,regulation of glucose catabolic process to lactate via pyruvate (GO:1904023),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
386,GO_Biological_Process_2017b,regulation of glycolytic fermentation to ethanol (GO:2001154),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
385,GO_Biological_Process_2017b,regulation of protein polyubiquitination (GO:1902914),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
384,GO_Biological_Process_2017b,regulation of protein monoubiquitination (GO:1902525),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
383,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
382,GO_Biological_Process_2017b,axonal transport of mitochondrion (GO:0019896),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,LRPPRC
388,GO_Biological_Process_2017b,regulation of synaptic vesicle transport (GO:1902803),1/12,0.0172664743371053,0.1403198996607425,0,0,64.8051948051948,263.043544162992,PRKN
457,GO_Biological_Process_2017b,mannosyl-inositol phosphorylceramide biosynthetic process (GO:0051999),1/18,0.02579144685281,0.1403198996607425,0,0,41.92016806722689,153.33191684558912,LARGE1
433,GO_Biological_Process_2017b,dopamine biosynthetic process (GO:0042416),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
432,GO_Biological_Process_2017b,free ubiquitin chain polymerization (GO:0010994),1/16,0.0229577530466617,0.1403198996607425,0,0,47.51428571428571,179.32364557493287,PRKN
127,GO_Biological_Process_2018,glycoprotein metabolic process (GO:0009100),1/48,0.0673564938105515,0.142039145371396,0,0,15.139817629179332,40.84353327133134,LARGE1
128,GO_Biological_Process_2018,protein K48-linked ubiquitination (GO:0070936),1/48,0.0673564938105515,0.142039145371396,0,0,15.139817629179332,40.84353327133134,PRKN
129,GO_Biological_Process_2018,regulation of mitochondrion organization (GO:0010821),1/48,0.0673564938105515,0.142039145371396,0,0,15.139817629179332,40.84353327133134,PRKN
130,GO_Biological_Process_2018,cellular macromolecule catabolic process (GO:0044265),1/48,0.0673564938105515,0.142039145371396,0,0,15.139817629179332,40.84353327133134,PRKN
131,GO_Biological_Process_2018,establishment of protein localization to mitochondrion (GO:0072655),1/49,0.0687120775442854,0.142039145371396,0,0,14.823660714285714,39.695247728368734,MAIP1
132,GO_Biological_Process_2018,regulation of reactive oxygen species metabolic process (GO:2000377),1/49,0.0687120775442854,0.142039145371396,0,0,14.823660714285714,39.695247728368734,PRKN
133,GO_Biological_Process_2018,protein autoubiquitination (GO:0051865),1/49,0.0687120775442854,0.142039145371396,0,0,14.823660714285714,39.695247728368734,PRKN
134,GO_Biological_Process_2018,regulation of ion transport (GO:0043269),1/50,0.0700657588372089,0.1427074646904917,0,0,14.520408163265309,38.5999069065122,PRKN
135,GO_Biological_Process_2018,negative regulation of viral genome replication (GO:0045071),1/50,0.0700657588372089,0.1427074646904917,0,0,14.520408163265309,38.5999069065122,PRKN
297,WikiPathways_2019_Human,miRNAs involved in DNA damage response WP1545,1/15,0.0215379237658092,0.1435861584387281,0,0,50.910714285714285,195.39226686727991,CDC25A
295,WikiPathways_2019_Human,EDA Signalling in Hair Follicle Development WP3930,1/13,0.0186922870807393,0.1435861584387281,0,0,59.40178571428572,236.3979776770167,EDAR
296,WikiPathways_2019_Human,Integrated Breast Cancer Pathway WP1984,2/151,0.0201193223078025,0.1435861584387281,0,0,9.854337559035546,38.4917778050494,EDAR;CDC25A
458,GO_Biological_Process_2017b,insulin receptor signaling pathway (GO:0008286),2/177,0.0270390736773098,0.1439846013704081,0,0,8.379259259259259,30.25308333184365,PTPRT;ITK
459,GO_Biological_Process_2017b,positive regulation of dopamine secretion (GO:0033603),1/19,0.0272053167113753,0.1439846013704081,0,0,39.58928571428572,142.69335919589085,PRKN
460,GO_Biological_Process_2017b,positive regulation of mitochondrion organization (GO:0010822),1/19,0.0272053167113753,0.1439846013704081,0,0,39.58928571428572,142.69335919589085,PRKN
461,GO_Biological_Process_2017b,negative regulation of cohesin unloading (GO:1905338),1/19,0.0272053167113753,0.1439846013704081,0,0,39.58928571428572,142.69335919589085,PRKN
136,GO_Biological_Process_2018,response to organonitrogen compound (GO:0010243),1/51,0.0714175402605397,0.144398968264011,0,0,14.229285714285714,37.55409844816487,PRKN
468,GO_Biological_Process_2017b,proteoglycan biosynthetic process (GO:0030166),1/20,0.0286172054274548,0.1445726352114276,0,0,37.50375939849624,133.2788782141628,LARGE1
467,GO_Biological_Process_2017b,mitochondrial nucleoid organization involved in mitochondrial fission (GO:0090145),1/20,0.0286172054274548,0.1445726352114276,0,0,37.50375939849624,133.2788782141628,PRKN
466,GO_Biological_Process_2017b,skeletal muscle tissue development (GO:0007519),1/20,0.0286172054274548,0.1445726352114276,0,0,37.50375939849624,133.2788782141628,LARGE1
462,GO_Biological_Process_2017b,protein insertion into mitochondrial membrane (GO:0051204),1/20,0.0286172054274548,0.1445726352114276,0,0,37.50375939849624,133.2788782141628,MAIP1
465,GO_Biological_Process_2017b,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/20,0.0286172054274548,0.1445726352114276,0,0,37.50375939849624,133.2788782141628,PRKN
463,GO_Biological_Process_2017b,establishment of mitochondrion localization involved in mitochondrial fission (GO:0090146),1/20,0.0286172054274548,0.1445726352114276,0,0,37.50375939849624,133.2788782141628,PRKN
464,GO_Biological_Process_2017b,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152),1/20,0.0286172054274548,0.1445726352114276,0,0,37.50375939849624,133.2788782141628,PRKN
137,GO_Biological_Process_2018,regulation of DNA binding (GO:0051101),1/52,0.0727674243643111,0.1460621489051752,0,0,13.949579831932772,36.55469109076161,PRKN
140,GO_Biological_Process_2018,negative regulation of supramolecular fiber organization (GO:1902904),1/54,0.0754615109632623,0.1482470818214445,0,0,13.421832884097036,34.683795119411634,PRKN
138,GO_Biological_Process_2018,RNA modification (GO:0009451),1/54,0.0754615109632623,0.1482470818214445,0,0,13.421832884097036,34.683795119411634,LRPPRC
139,GO_Biological_Process_2018,glycosphingolipid metabolic process (GO:0006687),1/54,0.0754615109632623,0.1482470818214445,0,0,13.421832884097036,34.683795119411634,LARGE1
141,GO_Biological_Process_2018,regulation of cellular catabolic process (GO:0031329),1/55,0.0768057185673521,0.149289702306236,0,0,13.172619047619047,33.80721302826248,PRKN
142,GO_Biological_Process_2018,cellular defense response (GO:0006968),1/56,0.0781480391133726,0.149289702306236,0,0,12.932467532467532,32.96680366793903,ITK
143,GO_Biological_Process_2018,organonitrogen compound catabolic process (GO:1901565),1/56,0.0781480391133726,0.149289702306236,0,0,12.932467532467532,32.96680366793903,PGC
144,GO_Biological_Process_2018,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/56,0.0781480391133726,0.149289702306236,0,0,12.932467532467532,32.96680366793903,PRKN
469,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079),1/21,0.0300271156735161,0.1507167483483585,0,0,35.62678571428572,124.89519987020886,PRKN
298,WikiPathways_2019_Human,Ciliary landscape WP4352,2/216,0.0389385345008201,0.1508586611730267,0,0,6.838698511595708,22.196848722300278,MCM9;LRPPRC
307,WikiPathways_2019_Human,miRNA Regulation of DNA Damage Response WP1530,1/71,0.0980581297624673,0.1508586611730267,0,0,10.153571428571428,23.578570928414106,CDC25A
306,WikiPathways_2019_Human,Parkin-Ubiquitin Proteasomal System pathway WP2359,1/70,0.0967438103878096,0.1508586611730267,0,0,10.301242236024844,24.06049739864184,PRKN
304,WikiPathways_2019_Human,G1 to S cell cycle control WP45,1/64,0.088818975374761,0.1508586611730267,0,0,11.285714285714286,27.32446317822344,CDC25A
302,WikiPathways_2019_Human,Integrated Cancer Pathway WP1971,1/44,0.0619150828416609,0.1508586611730267,0,0,16.551495016611295,46.04611785804375,CDC25A
299,WikiPathways_2019_Human,T-Cell Receptor and Co-stimulatory Signaling WP2583,1/29,0.0412354916064529,0.1508586611730267,0,0,25.4375,81.10634814419134,ITK
300,WikiPathways_2019_Human,Parkinsons Disease Pathway WP2371,1/38,0.0536954534974879,0.1508586611730267,0,0,19.24131274131274,56.26981345523857,PRKN
301,WikiPathways_2019_Human,ATM Signaling Pathway WP2516,1/40,0.0564430260228561,0.1508586611730267,0,0,18.25274725274725,52.46795162162656,CDC25A
305,WikiPathways_2019_Human,DNA Damage Response WP707,1/68,0.0941096218827057,0.1508586611730267,0,0,10.609808102345417,25.074106290081968,CDC25A
303,WikiPathways_2019_Human,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,1/62,0.0861624770957202,0.1508586611730267,0,0,11.656908665105387,28.577150519464418,ITK
470,GO_Biological_Process_2017b,positive regulation of mitochondrial fission (GO:0090141),1/22,0.031435050111481,0.1557736878135814,0,0,33.92857142857143,117.38714910240454,PRKN
471,GO_Biological_Process_2017b,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/22,0.031435050111481,0.1557736878135814,0,0,33.92857142857143,117.38714910240454,PRKN
145,GO_Biological_Process_2018,positive regulation of protein binding (GO:0032092),1/60,0.0834985018208404,0.1573407143154612,0,0,12.053268765133172,29.927381507961847,PRKN
146,GO_Biological_Process_2018,muscle organ development (GO:0007517),1/60,0.0834985018208404,0.1573407143154612,0,0,12.053268765133172,29.927381507961847,LARGE1
148,GO_Biological_Process_2018,positive regulation of catabolic process (GO:0009896),1/62,0.0861624770957202,0.1591133743700968,0,0,11.656908665105387,28.577150519464418,PRKN
147,GO_Biological_Process_2018,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/62,0.0861624770957202,0.1591133743700968,0,0,11.656908665105387,28.577150519464418,PRKN
149,GO_Biological_Process_2018,cellular protein catabolic process (GO:0044257),1/62,0.0861624770957202,0.1591133743700968,0,0,11.656908665105387,28.577150519464418,PRKN
150,GO_Biological_Process_2018,negative regulation of neuron apoptotic process (GO:0043524),1/63,0.0874916595913277,0.1594420375447223,0,0,11.46831797235023,27.9392516749594,PRKN
151,GO_Biological_Process_2018,negative regulation of protein modification process (GO:0031400),1/63,0.0874916595913277,0.1594420375447223,0,0,11.46831797235023,27.9392516749594,PRKN
478,GO_Biological_Process_2017b,protein catabolic process (GO:0030163),1/24,0.0342450021823671,0.1604976608306124,0,0,30.975155279503102,104.51682262493934,PGC
472,GO_Biological_Process_2017b,cohesin loading (GO:0071921),1/23,0.0328410113902878,0.1604976608306124,0,0,32.38474025974026,110.62877274373584,PRKN
473,GO_Biological_Process_2017b,catabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052363),1/23,0.0328410113902878,0.1604976608306124,0,0,32.38474025974026,110.62877274373584,PGC
474,GO_Biological_Process_2017b,positive regulation of cohesin loading (GO:1905309),1/24,0.0342450021823671,0.1604976608306124,0,0,30.975155279503102,104.51682262493934,PRKN
480,GO_Biological_Process_2017b,mitochondrial membrane fission (GO:0090149),1/24,0.0342450021823671,0.1604976608306124,0,0,30.975155279503102,104.51682262493934,PRKN
479,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827),1/24,0.0342450021823671,0.1604976608306124,0,0,30.975155279503102,104.51682262493934,PRKN
475,GO_Biological_Process_2017b,positive regulation of DNA binding (GO:0043388),1/24,0.0342450021823671,0.1604976608306124,0,0,30.975155279503102,104.51682262493934,PRKN
477,GO_Biological_Process_2017b,negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179),1/24,0.0342450021823671,0.1604976608306124,0,0,30.975155279503102,104.51682262493934,PRKN
476,GO_Biological_Process_2017b,hemoglobin catabolic process (GO:0042540),1/24,0.0342450021823671,0.1604976608306124,0,0,30.975155279503102,104.51682262493934,PGC
154,GO_Biological_Process_2018,cellular response to light stimulus (GO:0071482),1/66,0.0914680169101072,0.160642250715714,0,0,10.937362637362638,26.159611098844096,CDC25A
155,GO_Biological_Process_2018,sphingolipid biosynthetic process (GO:0030148),1/66,0.0914680169101072,0.160642250715714,0,0,10.937362637362638,26.159611098844096,LARGE1
158,GO_Biological_Process_2018,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/67,0.0927897477058275,0.160642250715714,0,0,10.771103896103895,25.607428374118918,CDC25A
153,GO_Biological_Process_2018,negative regulation of apoptotic signaling pathway (GO:2001234),1/65,0.090144426983272,0.160642250715714,0,0,11.108816964285714,26.73161450467769,PRKN
152,GO_Biological_Process_2018,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/64,0.088818975374761,0.160642250715714,0,0,11.285714285714286,27.32446317822344,PTPRT
159,GO_Biological_Process_2018,cellular response to UV (GO:0034644),1/67,0.0927897477058275,0.160642250715714,0,0,10.771103896103895,25.607428374118918,CDC25A
157,GO_Biological_Process_2018,positive regulation of autophagy (GO:0010508),1/67,0.0927897477058275,0.160642250715714,0,0,10.771103896103895,25.607428374118918,PRKN
156,GO_Biological_Process_2018,positive regulation of cellular protein localization (GO:1903829),1/66,0.0914680169101072,0.160642250715714,0,0,10.937362637362638,26.159611098844096,PRKN
309,WikiPathways_2019_Human,T-Cell antigen Receptor (TCR)  Signaling Pathway WP69,1/90,0.1226821823509282,0.1635762431345709,0,0,7.978330658105939,16.73979950106851,ITK
308,WikiPathways_2019_Human,Retinoblastoma Gene in Cancer WP2446,1/87,0.1188377972199883,0.1635762431345709,0,0,8.257890365448505,17.589271499945774,CDC25A
160,GO_Biological_Process_2018,negative regulation of developmental process (GO:0051093),1/70,0.0967438103878096,0.1638431958586282,0,0,10.301242236024844,24.06049739864184,PRKN
162,GO_Biological_Process_2018,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/70,0.0967438103878096,0.1638431958586282,0,0,10.301242236024844,24.06049739864184,PRKN
163,GO_Biological_Process_2018,recombinational repair (GO:0000725),1/71,0.0980581297624673,0.1638431958586282,0,0,10.153571428571428,23.578570928414106,MCM9
164,GO_Biological_Process_2018,cellular macromolecule biosynthetic process (GO:0034645),2/367,0.0986187694061063,0.1638431958586282,0,0,3.978893962455606,9.217082703099484,LARGE1;CDC25A
165,GO_Biological_Process_2018,glycoprotein biosynthetic process (GO:0009101),1/72,0.0993706025424171,0.1638431958586282,0,0,10.010060362173038,23.112217941062152,LARGE1
166,GO_Biological_Process_2018,regulation of neuron death (GO:1901214),1/72,0.0993706025424171,0.1638431958586282,0,0,10.010060362173038,23.112217941062152,PRKN
167,GO_Biological_Process_2018,lysosomal transport (GO:0007041),1/72,0.0993706025424171,0.1638431958586282,0,0,10.010060362173038,23.112217941062152,PRKN
161,GO_Biological_Process_2018,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/70,0.0967438103878096,0.1638431958586282,0,0,10.301242236024844,24.06049739864184,PRKN
481,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239),1/25,0.0356470251349897,0.1641028731066393,0,0,29.683035714285715,98.96590013795104,PRKN
482,GO_Biological_Process_2017b,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/25,0.0356470251349897,0.1641028731066393,0,0,29.683035714285715,98.96590013795104,PRKN
483,GO_Biological_Process_2017b,oogenesis (GO:0048477),1/25,0.0356470251349897,0.1641028731066393,0,0,29.683035714285715,98.96590013795104,MCM9
168,GO_Biological_Process_2018,positive regulation of proteasomal protein catabolic process (GO:1901800),1/73,0.1006812312455331,0.1650218997338028,0,0,9.870535714285714,22.660735221252363,PRKN
484,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/26,0.0370470829069464,0.1656473017333584,0,0,28.494285714285716,93.90478962861955,PRKN
488,GO_Biological_Process_2017b,mitochondrial respiratory chain complex IV assembly (GO:0033617),1/26,0.0370470829069464,0.1656473017333584,0,0,28.494285714285716,93.90478962861955,MAIP1
487,GO_Biological_Process_2017b,insulin catabolic process (GO:1901143),1/26,0.0370470829069464,0.1656473017333584,0,0,28.494285714285716,93.90478962861955,PGC
486,GO_Biological_Process_2017b,positive regulation of mitophagy (GO:1901526),1/26,0.0370470829069464,0.1656473017333584,0,0,28.494285714285716,93.90478962861955,PRKN
485,GO_Biological_Process_2017b,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/26,0.0370470829069464,0.1656473017333584,0,0,28.494285714285716,93.90478962861955,PRKN
490,GO_Biological_Process_2017b,protein destabilization (GO:0031648),1/27,0.0384451781473962,0.1661686033259682,0,0,27.396978021978025,89.27365552728025,PRKN
492,GO_Biological_Process_2017b,autophagy of mitochondrion (GO:0000422),1/27,0.0384451781473962,0.1661686033259682,0,0,27.396978021978025,89.27365552728025,PRKN
493,GO_Biological_Process_2017b,lipoprotein catabolic process (GO:0042159),1/27,0.0384451781473962,0.1661686033259682,0,0,27.396978021978025,89.27365552728025,PGC
494,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/27,0.0384451781473962,0.1661686033259682,0,0,27.396978021978025,89.27365552728025,PRKN
489,GO_Biological_Process_2017b,micromitophagy (GO:0000424),1/27,0.0384451781473962,0.1661686033259682,0,0,27.396978021978025,89.27365552728025,PRKN
491,GO_Biological_Process_2017b,positive regulation of proteasomal protein catabolic process (GO:1901800),1/27,0.0384451781473962,0.1661686033259682,0,0,27.396978021978025,89.27365552728025,PRKN
498,GO_Biological_Process_2017b,cristae formation (GO:0042407),1/28,0.0398413134963124,0.1666480747318876,0,0,26.38095238095238,85.02187553087816,MAIP1
500,GO_Biological_Process_2017b,lactosylceramide biosynthetic process (GO:0001572),1/28,0.0398413134963124,0.1666480747318876,0,0,26.38095238095238,85.02187553087816,LARGE1
499,GO_Biological_Process_2017b,"retrograde protein transport, ER to cytosol (GO:0030970)",1/28,0.0398413134963124,0.1666480747318876,0,0,26.38095238095238,85.02187553087816,PRKN
497,GO_Biological_Process_2017b,mitophagy by induced vacuole formation (GO:0035695),1/28,0.0398413134963124,0.1666480747318876,0,0,26.38095238095238,85.02187553087816,PRKN
496,GO_Biological_Process_2017b,mitophagy (GO:0000423),1/28,0.0398413134963124,0.1666480747318876,0,0,26.38095238095238,85.02187553087816,PRKN
495,GO_Biological_Process_2017b,cellular protein catabolic process (GO:0044257),2/216,0.0389385345008201,0.1666480747318876,0,0,6.838698511595708,22.196848722300278,PRKN;PGC
169,GO_Biological_Process_2018,negative regulation of phosphorylation (GO:0042326),1/75,0.1032969663744447,0.1683132922689481,0,0,9.602799227799228,21.799768455453663,PRKN
170,GO_Biological_Process_2018,double-strand break repair via homologous recombination (GO:0000724),1/76,0.1046020777922812,0.1684579973747784,0,0,9.474285714285717,21.3890703398866,MCM9
171,GO_Biological_Process_2018,positive regulation of JNK cascade (GO:0046330),1/76,0.1046020777922812,0.1684579973747784,0,0,9.474285714285717,21.3890703398866,EDAR
172,GO_Biological_Process_2018,ERAD pathway (GO:0036503),1/77,0.1059053551062263,0.169571002106501,0,0,9.349154135338344,20.99080930838857,PRKN
176,GO_Biological_Process_2018,positive regulation of stress-activated MAPK cascade (GO:0032874),1/80,0.109804207201114,0.1700262314294025,0,0,8.992766726943943,19.865529194835588,EDAR
178,GO_Biological_Process_2018,positive regulation of protein catabolic process (GO:0045732),1/81,0.1111001728834724,0.1700262314294025,0,0,8.879910714285714,19.512032283374484,PRKN
177,GO_Biological_Process_2018,positive regulation of binding (GO:0051099),1/81,0.1111001728834724,0.1700262314294025,0,0,8.879910714285714,19.512032283374484,PRKN
179,GO_Biological_Process_2018,epidermis development (GO:0008544),1/81,0.1111001728834724,0.1700262314294025,0,0,8.879910714285714,19.512032283374484,EDAR
174,GO_Biological_Process_2018,peptidyl-tyrosine phosphorylation (GO:0018108),1/79,0.1085064173227218,0.1700262314294025,0,0,9.108516483516484,20.22952290313978,ITK
173,GO_Biological_Process_2018,fibroblast growth factor receptor signaling pathway (GO:0008543),1/78,0.1072068007866111,0.1700262314294025,0,0,9.227272727272728,20.60445932788025,FRS3
175,GO_Biological_Process_2018,regulation of protein serine/threonine kinase activity (GO:0071900),1/80,0.109804207201114,0.1700262314294025,0,0,8.992766726943943,19.865529194835588,CDC25A
180,GO_Biological_Process_2018,negative regulation of cell death (GO:0060548),1/81,0.1111001728834724,0.1700262314294025,0,0,8.879910714285714,19.512032283374484,PRKN
181,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",3/813,0.1121063714554371,0.1706234334788795,0,0,2.72948717948718,5.972956210455885,ATF7IP;PRKN;GLIS3
502,GO_Biological_Process_2017b,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/29,0.0412354916064529,0.1706447471798955,0,0,25.4375,81.10634814419134,PRKN
501,GO_Biological_Process_2017b,negative regulation of stress fiber assembly (GO:0051497),1/29,0.0412354916064529,0.1706447471798955,0,0,25.4375,81.10634814419134,PRKN
526,GO_Biological_Process_2017b,extraocular skeletal muscle development (GO:0002074),1/34,0.0481771158578003,0.1710252297229122,0,0,21.57792207792208,65.4430572478459,LARGE1
551,GO_Biological_Process_2017b,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/37,0.0523187720746184,0.1710252297229122,0,0,19.776785714285715,58.34942939474461,PRKN
523,GO_Biological_Process_2017b,protein K33-linked deubiquitination (GO:1990168),2/243,0.0481438112872211,0.1710252297229122,0,0,6.0642385123712925,18.39624762682949,PRKN;CDC25A
522,GO_Biological_Process_2017b,protein K29-linked deubiquitination (GO:0035523),2/243,0.0481438112872211,0.1710252297229122,0,0,6.0642385123712925,18.39624762682949,PRKN;CDC25A
521,GO_Biological_Process_2017b,protein K11-linked deubiquitination (GO:0035871),2/243,0.0481438112872211,0.1710252297229122,0,0,6.0642385123712925,18.39624762682949,PRKN;CDC25A
520,GO_Biological_Process_2017b,protein K27-linked deubiquitination (GO:1990167),2/243,0.0481438112872211,0.1710252297229122,0,0,6.0642385123712925,18.39624762682949,PRKN;CDC25A
519,GO_Biological_Process_2017b,protein K48-linked deubiquitination (GO:0071108),2/243,0.0481438112872211,0.1710252297229122,0,0,6.0642385123712925,18.39624762682949,PRKN;CDC25A
518,GO_Biological_Process_2017b,protein deubiquitination (GO:0016579),2/243,0.0481438112872211,0.1710252297229122,0,0,6.0642385123712925,18.39624762682949,PRKN;CDC25A
516,GO_Biological_Process_2017b,protein K6-linked deubiquitination (GO:0044313),2/242,0.0477897581390303,0.1710252297229122,0,0,6.089814814814815,18.51878537959357,PRKN;CDC25A
515,GO_Biological_Process_2017b,protein O-linked glycosylation via hydroxyproline (GO:0018258),1/33,0.0467926844046366,0.1710252297229122,0,0,22.253348214285715,68.14038432553451,LARGE1
514,GO_Biological_Process_2017b,protein O-linked glycosylation via tyrosine (GO:0018245),1/33,0.0467926844046366,0.1710252297229122,0,0,22.253348214285715,68.14038432553451,LARGE1
524,GO_Biological_Process_2017b,protein linear deubiquitination (GO:1990108),2/243,0.0481438112872211,0.1710252297229122,0,0,6.0642385123712925,18.39624762682949,PRKN;CDC25A
513,GO_Biological_Process_2017b,low-density lipoprotein particle receptor catabolic process (GO:0032802),1/33,0.0467926844046366,0.1710252297229122,0,0,22.253348214285715,68.14038432553451,PRKN
511,GO_Biological_Process_2017b,mitochondrial calcium uptake (GO:0036444),1/32,0.0454063088797545,0.1710252297229122,0,0,22.972350230414747,71.03290112478346,MAIP1
510,GO_Biological_Process_2017b,positive regulation of proteasome-activating ATPase activity (GO:1902887),1/32,0.0454063088797545,0.1710252297229122,0,0,22.972350230414747,71.03290112478346,PRKN
509,GO_Biological_Process_2017b,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/32,0.0454063088797545,0.1710252297229122,0,0,22.972350230414747,71.03290112478346,CDC25A
508,GO_Biological_Process_2017b,activation of phospholipase C activity (GO:0007202),1/32,0.0454063088797545,0.1710252297229122,0,0,22.972350230414747,71.03290112478346,ITK
507,GO_Biological_Process_2017b,mitochondrial DNA inheritance (GO:0033955),1/31,0.044017986659766,0.1710252297229122,0,0,23.739285714285717,74.14151494993529,PRKN
506,GO_Biological_Process_2017b,ER-associated misfolded protein catabolic process (GO:0071712),1/30,0.0426277151111442,0.1710252297229122,0,0,24.55911330049261,77.49015815040234,PRKN
505,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/30,0.0426277151111442,0.1710252297229122,0,0,24.55911330049261,77.49015815040234,PRKN
504,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway (GO:0060828),1/30,0.0426277151111442,0.1710252297229122,0,0,24.55911330049261,77.49015815040234,PRKN
503,GO_Biological_Process_2017b,glycosylceramide biosynthetic process (GO:0046476),1/30,0.0426277151111442,0.1710252297229122,0,0,24.55911330049261,77.49015815040234,LARGE1
512,GO_Biological_Process_2017b,"protein catabolic process, modulating synaptic transmission (GO:0099546)",1/33,0.0467926844046366,0.1710252297229122,0,0,22.253348214285715,68.14038432553451,PGC
525,GO_Biological_Process_2017b,protein O-linked glycosylation via serine (GO:0018242),1/34,0.0481771158578003,0.1710252297229122,0,0,21.57792207792208,65.4430572478459,LARGE1
527,GO_Biological_Process_2017b,ganglioside biosynthetic process (GO:0001574),1/34,0.0481771158578003,0.1710252297229122,0,0,21.57792207792208,65.4430572478459,LARGE1
528,GO_Biological_Process_2017b,protein K63-linked deubiquitination (GO:0070536),2/244,0.04849884162573,0.1710252297229122,0,0,6.03887358432813,18.27493203017617,PRKN;CDC25A
550,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced cell death (GO:1903202),1/37,0.0523187720746184,0.1710252297229122,0,0,19.776785714285715,58.34942939474461,PRKN
549,GO_Biological_Process_2017b,memory T cell activation (GO:0035709),1/37,0.0523187720746184,0.1710252297229122,0,0,19.776785714285715,58.34942939474461,ITK
548,GO_Biological_Process_2017b,negative regulation of JNK cascade (GO:0046329),1/37,0.0523187720746184,0.1710252297229122,0,0,19.776785714285715,58.34942939474461,PRKN
547,GO_Biological_Process_2017b,alpha-beta T cell activation (GO:0046631),1/37,0.0523187720746184,0.1710252297229122,0,0,19.776785714285715,58.34942939474461,ITK
545,GO_Biological_Process_2017b,positive regulation of I-kappaB phosphorylation (GO:1903721),2/252,0.0513738616093863,0.1710252297229122,0,0,5.843259259259259,17.3464499878289,EDAR;PRKN
544,GO_Biological_Process_2017b,protein S-linked glycosylation (GO:0018280),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,LARGE1
543,GO_Biological_Process_2017b,protein glycosylation at cell surface (GO:0033575),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,LARGE1
542,GO_Biological_Process_2017b,protein glycosylation in Golgi (GO:0033578),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,LARGE1
541,GO_Biological_Process_2017b,protein glycosylation in cytosol (GO:0033576),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,LARGE1
540,GO_Biological_Process_2017b,cellular response to unfolded protein (GO:0034620),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,PRKN
539,GO_Biological_Process_2017b,protein glucuronylation (GO:0018321),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,LARGE1
538,GO_Biological_Process_2017b,T cell activation (GO:0042110),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,ITK
537,GO_Biological_Process_2017b,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle (GO:0031660),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,CDC25A
536,GO_Biological_Process_2017b,protein C-linked glycosylation (GO:0018103),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,LARGE1
535,GO_Biological_Process_2017b,protein galactosylation (GO:0042125),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,LARGE1
534,GO_Biological_Process_2017b,protein phosphate-linked glycosylation (GO:0042076),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,LARGE1
533,GO_Biological_Process_2017b,protein import into mitochondrial inner membrane (GO:0045039),1/36,0.0509401570739593,0.1710252297229122,0,0,20.34285714285714,60.56279579598777,MAIP1
532,GO_Biological_Process_2017b,histone deubiquitination (GO:0016578),2/250,0.0506493570161387,0.1710252297229122,0,0,5.8909796893667865,17.571783541959874,PRKN;CDC25A
531,GO_Biological_Process_2017b,protein O-linked glycosylation via threonine (GO:0018243),1/35,0.049559605875515,0.1710252297229122,0,0,20.942226890756302,62.92257878831688,LARGE1
530,GO_Biological_Process_2017b,protein O-linked glycosylation via hydroxylysine (GO:0018241),1/35,0.049559605875515,0.1710252297229122,0,0,20.942226890756302,62.92257878831688,LARGE1
529,GO_Biological_Process_2017b,chaperone-mediated autophagy (GO:0061684),1/35,0.049559605875515,0.1710252297229122,0,0,20.942226890756302,62.92257878831688,PGC
552,GO_Biological_Process_2017b,glycoprotein catabolic process (GO:0006516),1/37,0.0523187720746184,0.1710252297229122,0,0,19.776785714285715,58.34942939474461,PGC
517,GO_Biological_Process_2017b,monoubiquitinated protein deubiquitination (GO:0035520),2/242,0.0477897581390303,0.1710252297229122,0,0,6.089814814814815,18.51878537959357,PRKN;CDC25A
546,GO_Biological_Process_2017b,negative regulation of necrotic cell death (GO:0060547),1/37,0.0523187720746184,0.1710252297229122,0,0,19.776785714285715,58.34942939474461,PRKN
555,GO_Biological_Process_2017b,regulation of synaptic vesicle exocytosis (GO:2000300),1/38,0.0536954534974879,0.1712092738567444,0,0,19.24131274131274,56.26981345523857,PRKN
553,GO_Biological_Process_2017b,tRNA modification (GO:0006400),1/38,0.0536954534974879,0.1712092738567444,0,0,19.24131274131274,56.26981345523857,LRPPRC
554,GO_Biological_Process_2017b,histone H2A K63-linked ubiquitination (GO:0070535),1/38,0.0536954534974879,0.1712092738567444,0,0,19.24131274131274,56.26981345523857,PRKN
556,GO_Biological_Process_2017b,protein glycosylation in endoplasmic reticulum (GO:0033577),1/38,0.0536954534974879,0.1712092738567444,0,0,19.24131274131274,56.26981345523857,LARGE1
557,GO_Biological_Process_2017b,protein mannosylation (GO:0035268),1/38,0.0536954534974879,0.1712092738567444,0,0,19.24131274131274,56.26981345523857,LARGE1
558,GO_Biological_Process_2017b,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/38,0.0536954534974879,0.1712092738567444,0,0,19.24131274131274,56.26981345523857,PRKN
570,GO_Biological_Process_2017b,positive regulation of C-C chemokine binding (GO:2001265),1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,PRKN
560,GO_Biological_Process_2017b,establishment of T cell polarity (GO:0001768),1/39,0.055070203944055,0.1715338837725862,0,0,18.73402255639098,54.31267540736575,ITK
561,GO_Biological_Process_2017b,histone monoubiquitination (GO:0010390),1/39,0.055070203944055,0.1715338837725862,0,0,18.73402255639098,54.31267540736575,PRKN
559,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress by transcription from RNA polymerase II promoter (GO:0100038),2/260,0.0543095065013448,0.1715338837725862,0,0,5.659776055124892,16.487244560246975,PRKN;GLIS3
563,GO_Biological_Process_2017b,positive regulation of actin binding (GO:1904618),1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,PRKN
564,GO_Biological_Process_2017b,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,CDC25A
565,GO_Biological_Process_2017b,protein O-linked mannosylation (GO:0035269),1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,LARGE1
566,GO_Biological_Process_2017b,gamma-delta T cell activation (GO:0046629),1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,ITK
567,GO_Biological_Process_2017b,positive regulation of collagen binding (GO:0033343),1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,PRKN
568,GO_Biological_Process_2017b,positive regulation of apolipoprotein binding (GO:2000658),1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,PRKN
569,GO_Biological_Process_2017b,positive regulation of Ras GTPase binding (GO:1904477),1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,PRKN
562,GO_Biological_Process_2017b,"phototransduction, UV (GO:0007604)",1/40,0.0564430260228561,0.1715338837725862,0,0,18.25274725274725,52.46795162162656,CDC25A
182,GO_Biological_Process_2018,negative regulation of neuron death (GO:1901215),1/83,0.1136866415597872,0.1720830585358527,0,0,8.662456445993032,18.834860248996137,PRKN
578,GO_Biological_Process_2017b,mitochondrial calcium release (GO:0099093),1/42,0.0591828955366752,0.17245053456005,0,0,17.360627177700348,49.080623277270966,MAIP1
581,GO_Biological_Process_2017b,regulation of protein targeting to vacuole involved in autophagy (GO:1904051),1/42,0.0591828955366752,0.17245053456005,0,0,17.360627177700348,49.080623277270966,PRKN
580,GO_Biological_Process_2017b,positive regulation of receptor binding (GO:1900122),1/42,0.0591828955366752,0.17245053456005,0,0,17.360627177700348,49.080623277270966,PRKN
579,GO_Biological_Process_2017b,regulation of autophagy (GO:0010506),1/42,0.0591828955366752,0.17245053456005,0,0,17.360627177700348,49.080623277270966,PRKN
577,GO_Biological_Process_2017b,suppression by virus of host protein phosphorylation (GO:0039613),1/42,0.0591828955366752,0.17245053456005,0,0,17.360627177700348,49.080623277270966,PRKN
571,GO_Biological_Process_2017b,positive regulation of protein targeting to membrane (GO:0090314),1/41,0.0578139223569284,0.17245053456005,0,0,17.795535714285716,50.72663120626347,PRKN
575,GO_Biological_Process_2017b,positive regulation of microtubule binding (GO:1904528),1/42,0.0591828955366752,0.17245053456005,0,0,17.360627177700348,49.080623277270966,PRKN
574,GO_Biological_Process_2017b,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/41,0.0578139223569284,0.17245053456005,0,0,17.795535714285716,50.72663120626347,PRKN
573,GO_Biological_Process_2017b,T cell proliferation (GO:0042098),1/41,0.0578139223569284,0.17245053456005,0,0,17.795535714285716,50.72663120626347,ITK
572,GO_Biological_Process_2017b,positive regulation of heparan sulfate proteoglycan binding (GO:1905860),1/41,0.0578139223569284,0.17245053456005,0,0,17.795535714285716,50.72663120626347,PRKN
576,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767),1/42,0.0591828955366752,0.17245053456005,0,0,17.360627177700348,49.080623277270966,CDC25A
583,GO_Biological_Process_2017b,protein O-linked fucosylation (GO:0036066),1/43,0.0605499481664255,0.1738297404925426,0,0,16.946428571428573,47.52264366272739,LARGE1
585,GO_Biological_Process_2017b,negative regulation of cell death (GO:0060548),1/43,0.0605499481664255,0.1738297404925426,0,0,16.946428571428573,47.52264366272739,PRKN
584,GO_Biological_Process_2017b,negative regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901408),1/43,0.0605499481664255,0.1738297404925426,0,0,16.946428571428573,47.52264366272739,PRKN
582,GO_Biological_Process_2017b,epidermal growth factor catabolic process (GO:0007174),1/43,0.0605499481664255,0.1738297404925426,0,0,16.946428571428573,47.52264366272739,PRKN
586,GO_Biological_Process_2017b,positive regulation of elastin catabolic process (GO:0110015),1/44,0.0619150828416609,0.1764466463399715,0,0,16.551495016611295,46.04611785804375,PRKN
587,GO_Biological_Process_2017b,negative regulation of protein ubiquitination (GO:0031397),1/44,0.0619150828416609,0.1764466463399715,0,0,16.551495016611295,46.04611785804375,PRKN
183,GO_Biological_Process_2018,calcium ion transmembrane transport (GO:0070588),1/86,0.117552724870697,0.1769679608107775,0,0,8.35546218487395,17.887944321802927,MAIP1
186,GO_Biological_Process_2018,T cell activation (GO:0042110),1/88,0.1201210626217972,0.1779333387499349,0,0,8.16256157635468,17.298550980881092,ITK
185,GO_Biological_Process_2018,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/88,0.1201210626217972,0.1779333387499349,0,0,8.16256157635468,17.298550980881092,PRKN
184,GO_Biological_Process_2018,regulation of protein targeting to mitochondrion (GO:1903214),1/88,0.1201210626217972,0.1779333387499349,0,0,8.16256157635468,17.298550980881092,PRKN
187,GO_Biological_Process_2018,regulation of neuron apoptotic process (GO:0043523),1/89,0.1214025235104908,0.1788749947468403,0,0,8.06939935064935,17.015487408196194,PRKN
588,GO_Biological_Process_2017b,RNA modification (GO:0009451),1/45,0.0632783021573496,0.1796734272934965,0,0,16.17451298701299,44.64509756246689,LRPPRC
188,GO_Biological_Process_2018,regulation of protein catabolic process (GO:0042176),1/91,0.1239600415911738,0.1816768863532018,0,0,7.889285714285714,16.47121924030951,PRKN
590,GO_Biological_Process_2017b,cellular response to UV-A (GO:0071492),1/46,0.0646396086979469,0.1822087520543578,0,0,15.814285714285717,43.31418865156708,CDC25A
589,GO_Biological_Process_2017b,negative regulation of histone phosphorylation (GO:0033128),1/46,0.0646396086979469,0.1822087520543578,0,0,15.814285714285717,43.31418865156708,PRKN
189,GO_Biological_Process_2018,cell cycle G1/S phase transition (GO:0044843),1/92,0.1252361036613152,0.1825810563904437,0,0,7.802197802197802,16.209491106910413,CDC25A
190,GO_Biological_Process_2018,proteolysis involved in cellular protein catabolic process (GO:0051603),1/93,0.1265103709770979,0.1834731558149535,0,0,7.717003105590062,15.954371371707152,PRKN
191,GO_Biological_Process_2018,cellular response to fibroblast growth factor stimulus (GO:0044344),1/94,0.1277828460126215,0.1843533767994592,0,0,7.633640552995391,15.705627428388125,FRS3
591,GO_Biological_Process_2017b,negative regulation of programmed cell death (GO:0043069),1/47,0.0659990050555762,0.1847022515584112,0,0,15.46972049689441,42.048488795650734,PRKN
592,GO_Biological_Process_2017b,cellular response to UV-C (GO:0071494),1/47,0.0659990050555762,0.1847022515584112,0,0,15.46972049689441,42.048488795650734,CDC25A
194,GO_Biological_Process_2018,positive regulation of protein metabolic process (GO:0051247),1/96,0.1303224289056154,0.1851246810607973,0,0,7.472180451127819,15.226388466574354,PRKN
193,GO_Biological_Process_2018,regulation of cell death (GO:0010941),1/96,0.1303224289056154,0.1851246810607973,0,0,7.472180451127819,15.226388466574354,PRKN
192,GO_Biological_Process_2018,positive regulation of protein localization to membrane (GO:1905477),1/95,0.1290535311850947,0.1851246810607973,0,0,7.552051671732523,15.463037181836098,PRKN
195,GO_Biological_Process_2018,regulation of insulin secretion (GO:0050796),1/98,0.132854871702785,0.1868060886379262,0,0,7.317378497790869,14.77011340018396,PRKN
196,GO_Biological_Process_2018,response to UV (GO:0009411),1/98,0.132854871702785,0.1868060886379262,0,0,7.317378497790869,14.77011340018396,CDC25A
593,GO_Biological_Process_2017b,negative regulation of inhibitory G-protein coupled receptor phosphorylation (GO:1904324),1/48,0.0673564938105515,0.1878256350702836,0,0,15.139817629179332,40.84353327133134,PRKN
197,GO_Biological_Process_2018,cellular response to metal ion (GO:0071248),1/100,0.13538019382269,0.189395523681238,0,0,7.1688311688311686,14.335283778329618,PRKN
198,GO_Biological_Process_2018,regulation of protein ubiquitination (GO:0031396),1/101,0.1366401906284411,0.1901976522818,0,0,7.096785714285715,14.125471764544198,PRKN
594,GO_Biological_Process_2017b,modulation by virus of host autophagy (GO:0039519),1/49,0.0687120775442854,0.1902419798201213,0,0,14.823660714285714,39.695247728368734,PRKN
595,GO_Biological_Process_2017b,protein ADP-ribosylation (GO:0006471),1/49,0.0687120775442854,0.1902419798201213,0,0,14.823660714285714,39.695247728368734,LARGE1
596,GO_Biological_Process_2017b,negative regulation of protein autophosphorylation (GO:0031953),1/50,0.0700657588372089,0.193301987146626,0,0,14.520408163265309,38.5999069065122,PRKN
199,GO_Biological_Process_2018,regulation of cellular response to stress (GO:0080135),1/104,0.1404095530685888,0.1934997323383041,0,0,6.889042995839112,13.524512360401651,PRKN
200,GO_Biological_Process_2018,B cell receptor signaling pathway (GO:0050853),1/104,0.1404095530685888,0.1934997323383041,0,0,6.889042995839112,13.524512360401651,ITK
201,GO_Biological_Process_2018,G1/S transition of mitotic cell cycle (GO:0000082),1/105,0.1416624725419254,0.1942599252183829,0,0,6.822458791208791,13.333185827739708,CDC25A
202,GO_Biological_Process_2018,response to endoplasmic reticulum stress (GO:0034976),1/106,0.1429136286904141,0.1950102224002203,0,0,6.757142857142857,13.146121612489974,PRKN
598,GO_Biological_Process_2017b,positive regulation of protein homodimerization activity (GO:0090073),1/51,0.0714175402605397,0.1956438250799293,0,0,14.229285714285714,37.55409844816487,PRKN
597,GO_Biological_Process_2017b,negative regulation by host of viral genome replication (GO:0044828),1/51,0.0714175402605397,0.1956438250799293,0,0,14.229285714285714,37.55409844816487,PRKN
599,GO_Biological_Process_2017b,mitochondrion to lysosome transport (GO:0099074),1/52,0.0727674243643111,0.1979477487952239,0,0,13.949579831932772,36.55469109076161,PRKN
600,GO_Biological_Process_2017b,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/52,0.0727674243643111,0.1979477487952239,0,0,13.949579831932772,36.55469109076161,PTPRT
203,GO_Biological_Process_2018,regulation of Wnt signaling pathway (GO:0030111),1/109,0.1466565409888442,0.1991365777152443,0,0,6.568452380952381,12.60920765835375,PRKN
204,GO_Biological_Process_2018,macroautophagy (GO:0016236),1/110,0.1479006676495557,0.1998462679947656,0,0,6.507863695937091,12.43792277689215,PRKN
601,GO_Biological_Process_2017b,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/53,0.07411541375319,0.2002145552082702,0,0,13.680631868131869,35.598806618662685,PRKN
602,GO_Biological_Process_2017b,cellular response to UV-B (GO:0071493),1/53,0.07411541375319,0.2002145552082702,0,0,13.680631868131869,35.598806618662685,CDC25A
310,WikiPathways_2019_Human,Cell Cycle WP179,1/120,0.160245998558801,0.2003074981985012,0,0,5.957983193277311,10.909336250595471,CDC25A
205,GO_Biological_Process_2018,regulation of protein binding (GO:0043393),1/111,0.1491430429514568,0.2005467130949201,0,0,6.448376623376624,12.2702896774478,PRKN
207,GO_Biological_Process_2018,positive regulation of developmental process (GO:0051094),1/113,0.1516225488163737,0.2019204135679591,0,0,6.332589285714286,11.945549951152008,PRKN
206,GO_Biological_Process_2018,regulation of organelle organization (GO:0033043),1/113,0.1516225488163737,0.2019204135679591,0,0,6.332589285714286,11.945549951152008,PRKN
208,GO_Biological_Process_2018,positive regulation of intracellular signal transduction (GO:1902533),2/479,0.1525124694693445,0.2021337514019542,0,0,3.027253668763102,5.692777524987663,EDAR;PRKN
209,GO_Biological_Process_2018,protein O-linked glycosylation (GO:0006493),1/115,0.1540950775438487,0.2032587451411718,0,0,6.220864661654136,11.63417076591374,LARGE1
604,GO_Biological_Process_2017b,positive regulation of protein binding (GO:0032092),1/55,0.0768057185673521,0.2054271869358166,0,0,13.172619047619047,33.80721302826248,PRKN
605,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by transcription from RNA polymerase II promoter (GO:0100069),2/317,0.0768371611803633,0.2054271869358166,0,0,4.622222222222222,11.860931385655247,PRKN;GLIS3
603,GO_Biological_Process_2017b,T cell differentiation (GO:0030217),1/55,0.0768057185673521,0.2054271869358166,0,0,13.172619047619047,33.80721302826248,ITK
609,GO_Biological_Process_2017b,cellular defense response (GO:0006968),1/57,0.0794884751768759,0.2068295441057172,0,0,12.700892857142858,32.1604799159938,ITK
610,GO_Biological_Process_2017b,skeletal muscle organ development (GO:0060538),1/57,0.0794884751768759,0.2068295441057172,0,0,12.700892857142858,32.1604799159938,LARGE1
612,GO_Biological_Process_2017b,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/57,0.0794884751768759,0.2068295441057172,0,0,12.700892857142858,32.1604799159938,PRKN
611,GO_Biological_Process_2017b,positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786),1/57,0.0794884751768759,0.2068295441057172,0,0,12.700892857142858,32.1604799159938,PRKN
606,GO_Biological_Process_2017b,T cell activation involved in immune response (GO:0002286),1/56,0.0781480391133726,0.2068295441057172,0,0,12.932467532467532,32.96680366793903,ITK
607,GO_Biological_Process_2017b,regulation of chaperone-mediated autophagy (GO:1904714),1/56,0.0781480391133726,0.2068295441057172,0,0,12.932467532467532,32.96680366793903,PRKN
608,GO_Biological_Process_2017b,positive regulation of transcription factor catabolic process (GO:1901485),1/57,0.0794884751768759,0.2068295441057172,0,0,12.700892857142858,32.1604799159938,PRKN
613,GO_Biological_Process_2017b,negative regulation of JUN kinase activity (GO:0043508),1/57,0.0794884751768759,0.2068295441057172,0,0,12.700892857142858,32.1604799159938,PRKN
615,GO_Biological_Process_2017b,RNA-directed DNA methylation (GO:0080188),1/58,0.0808270292719347,0.2089150457593528,0,0,12.477443609022556,31.38630877384684,ATF7IP
614,GO_Biological_Process_2017b,intracellular defense response (GO:0002818),1/58,0.0808270292719347,0.2089150457593528,0,0,12.477443609022556,31.38630877384684,ITK
311,WikiPathways_2019_Human,Endoderm Differentiation WP2853,1/141,0.1856115798261867,0.2101936541339996,0,0,5.058928571428571,8.519736898653388,LRPPRC
312,WikiPathways_2019_Human,Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380,1/144,0.1891742887205996,0.2101936541339996,0,0,4.952047952047952,8.245588322597563,FRS3
618,GO_Biological_Process_2017b,protein N-linked glycosylation (GO:0006487),1/60,0.0834985018208404,0.2102324738401743,0,0,12.053268765133172,29.927381507961847,LARGE1
622,GO_Biological_Process_2017b,positive regulation of protein catabolic process (GO:0045732),1/60,0.0834985018208404,0.2102324738401743,0,0,12.053268765133172,29.927381507961847,PRKN
617,GO_Biological_Process_2017b,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/59,0.0821637039796816,0.2102324738401743,0,0,12.261699507389162,30.642497546322605,PRKN
616,GO_Biological_Process_2017b,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),2/329,0.0819075402665703,0.2102324738401743,0,0,4.449881073734285,11.13433323093521,PRKN;CDC25A
619,GO_Biological_Process_2017b,response to endoplasmic reticulum stress (GO:0034976),1/60,0.0834985018208404,0.2102324738401743,0,0,12.053268765133172,29.927381507961847,PRKN
620,GO_Biological_Process_2017b,positive regulation of protein ubiquitination (GO:0031398),1/60,0.0834985018208404,0.2102324738401743,0,0,12.053268765133172,29.927381507961847,PRKN
621,GO_Biological_Process_2017b,negative regulation of outer hair cell apoptotic process (GO:1905586),1/60,0.0834985018208404,0.2102324738401743,0,0,12.053268765133172,29.927381507961847,PRKN
623,GO_Biological_Process_2017b,regulation of translation involved in cellular response to UV (GO:1904803),1/60,0.0834985018208404,0.2102324738401743,0,0,12.053268765133172,29.927381507961847,CDC25A
210,GO_Biological_Process_2018,DNA replication (GO:0006260),1/120,0.160245998558801,0.2103703393402269,0,0,5.957983193277311,10.909336250595471,CDC25A
211,GO_Biological_Process_2018,tumor necrosis factor-mediated signaling pathway (GO:0033209),1/123,0.1639157991027448,0.2127561261056655,0,0,5.81059718969555,10.507897921340264,EDAR
214,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.1651356213455527,0.2127561261056655,0,0,5.7630662020905925,10.379214197813798,PTPRT
212,GO_Biological_Process_2018,cellular calcium ion homeostasis (GO:0006874),1/123,0.1639157991027448,0.2127561261056655,0,0,5.81059718969555,10.507897921340264,MAIP1
213,GO_Biological_Process_2018,negative regulation of macromolecule metabolic process (GO:0010605),1/124,0.1651356213455527,0.2127561261056655,0,0,5.7630662020905925,10.379214197813798,PRKN
624,GO_Biological_Process_2017b,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/61,0.0848314253435665,0.2128995126364346,0,0,11.851785714285716,29.239412808440157,PRKN
215,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.1663537252021877,0.2133332494491018,0,0,5.716301843317972,10.25298125318036,PTPRT
216,GO_Biological_Process_2018,G2/M transition of mitotic cell cycle (GO:0000086),1/126,0.1675701129945591,0.2139028631313035,0,0,5.670285714285714,10.129134336252406,CDC25A
627,GO_Biological_Process_2017b,endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857),1/62,0.0861624770957202,0.214167435081375,0,0,11.656908665105387,28.577150519464418,PRKN
626,GO_Biological_Process_2017b,regulation of translation in response to endoplasmic reticulum stress (GO:0036490),1/62,0.0861624770957202,0.214167435081375,0,0,11.656908665105387,28.577150519464418,PRKN
625,GO_Biological_Process_2017b,negative regulation of motor neuron apoptotic process (GO:2000672),1/62,0.0861624770957202,0.214167435081375,0,0,11.656908665105387,28.577150519464418,PRKN
217,GO_Biological_Process_2018,cell cycle G2/M phase transition (GO:0044839),1/127,0.1687847870526419,0.2144650734567973,0,0,5.625,10.007610890498013,CDC25A
218,GO_Biological_Process_2018,positive regulation of mitochondrion organization (GO:0010822),1/128,0.1699977496813081,0.215019984756723,0,0,5.580427446569179,9.888350464401547,PRKN
628,GO_Biological_Process_2017b,regulation of cell cycle (GO:0051726),1/63,0.0874916595913277,0.2154066808925728,0,0,11.46831797235023,27.9392516749594,CDC25A
630,GO_Biological_Process_2017b,modulation by symbiont of host cell cycle (GO:0044071),1/63,0.0874916595913277,0.2154066808925728,0,0,11.46831797235023,27.9392516749594,CDC25A
629,GO_Biological_Process_2017b,response to manganese-induced endoplasmic reticulum stress (GO:1990737),1/63,0.0874916595913277,0.2154066808925728,0,0,11.46831797235023,27.9392516749594,PRKN
632,GO_Biological_Process_2017b,mitochondrion organization (GO:0007005),1/64,0.088818975374761,0.2159411338798878,0,0,11.285714285714286,27.32446317822344,PRKN
633,GO_Biological_Process_2017b,sperm mitochondrion organization (GO:0030382),1/64,0.088818975374761,0.2159411338798878,0,0,11.285714285714286,27.32446317822344,PRKN
634,GO_Biological_Process_2017b,regulation of cell cycle checkpoint (GO:1901976),1/64,0.088818975374761,0.2159411338798878,0,0,11.285714285714286,27.32446317822344,CDC25A
631,GO_Biological_Process_2017b,regulation of meiotic cell cycle (GO:0051445),1/64,0.088818975374761,0.2159411338798878,0,0,11.285714285714286,27.32446317822344,CDC25A
219,GO_Biological_Process_2018,protein glycosylation (GO:0006486),1/130,0.1724185500532113,0.2170906289306342,0,0,5.493355481727575,9.65638686620222,LARGE1
636,GO_Biological_Process_2017b,mitochondrion disassembly (GO:0061726),1/65,0.090144426983272,0.2178023732701418,0,0,11.108816964285714,26.73161450467769,PRKN
635,GO_Biological_Process_2017b,ER overload response (GO:0006983),1/65,0.090144426983272,0.2178023732701418,0,0,11.108816964285714,26.73161450467769,PRKN
638,GO_Biological_Process_2017b,positive regulation of cellular protein catabolic process (GO:1903364),1/66,0.0914680169101072,0.2189603604801951,0,0,10.937362637362638,26.159611098844096,PRKN
637,GO_Biological_Process_2017b,mitochondrial membrane organization (GO:0007006),1/66,0.0914680169101072,0.2189603604801951,0,0,10.937362637362638,26.159611098844096,PRKN
639,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441),1/66,0.0914680169101072,0.2189603604801951,0,0,10.937362637362638,26.159611098844096,PRKN
640,GO_Biological_Process_2017b,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),1/67,0.0927897477058275,0.2198717292034387,0,0,10.771103896103895,25.607428374118918,PRKN
641,GO_Biological_Process_2017b,protein O-linked glycosylation (GO:0006493),1/67,0.0927897477058275,0.2198717292034387,0,0,10.771103896103895,25.607428374118918,LARGE1
642,GO_Biological_Process_2017b,mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),1/68,0.0941096218827057,0.2198717292034387,0,0,10.609808102345417,25.074106290081968,PRKN
643,GO_Biological_Process_2017b,double-strand break repair via synthesis-dependent strand annealing (GO:0045003),1/68,0.0941096218827057,0.2198717292034387,0,0,10.609808102345417,25.074106290081968,MCM9
644,GO_Biological_Process_2017b,epidermis development (GO:0008544),1/68,0.0941096218827057,0.2198717292034387,0,0,10.609808102345417,25.074106290081968,EDAR
645,GO_Biological_Process_2017b,replication-born double-strand break repair via sister chromatid exchange (GO:1990414),1/68,0.0941096218827057,0.2198717292034387,0,0,10.609808102345417,25.074106290081968,MCM9
646,GO_Biological_Process_2017b,mitochondrial calcium ion transmembrane transport (GO:0006851),1/68,0.0941096218827057,0.2198717292034387,0,0,10.609808102345417,25.074106290081968,MAIP1
647,GO_Biological_Process_2017b,regulation of cell cycle process (GO:0010564),1/68,0.0941096218827057,0.2198717292034387,0,0,10.609808102345417,25.074106290081968,CDC25A
220,GO_Biological_Process_2018,mitochondrial transport (GO:0006839),1/135,0.1784407637353149,0.2236565228718652,0,0,5.287046908315565,9.112217884678747,PRKN
313,WikiPathways_2019_Human,Chemokine signaling pathway WP3929,1/164,0.2125440005707,0.2237305269165263,0,0,4.340052585451359,6.721032561514259,ITK
653,GO_Biological_Process_2017b,mitochondrial genome maintenance (GO:0000002),1/72,0.0993706025424171,0.2250862008880022,0,0,10.010060362173038,23.112217941062152,PRKN
650,GO_Biological_Process_2017b,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/71,0.0980581297624673,0.2250862008880022,0,0,10.153571428571428,23.578570928414106,PRKN
651,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382),1/72,0.0993706025424171,0.2250862008880022,0,0,10.010060362173038,23.112217941062152,PRKN
652,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/72,0.0993706025424171,0.2250862008880022,0,0,10.010060362173038,23.112217941062152,PRKN
654,GO_Biological_Process_2017b,mitochondrion distribution (GO:0048311),1/72,0.0993706025424171,0.2250862008880022,0,0,10.010060362173038,23.112217941062152,PRKN
655,GO_Biological_Process_2017b,mitochondrion morphogenesis (GO:0070584),1/72,0.0993706025424171,0.2250862008880022,0,0,10.010060362173038,23.112217941062152,PRKN
656,GO_Biological_Process_2017b,positive regulation of JNK cascade (GO:0046330),1/72,0.0993706025424171,0.2250862008880022,0,0,10.010060362173038,23.112217941062152,EDAR
657,GO_Biological_Process_2017b,cellular response to UV (GO:0034644),1/72,0.0993706025424171,0.2250862008880022,0,0,10.010060362173038,23.112217941062152,CDC25A
658,GO_Biological_Process_2017b,torso signaling pathway (GO:0008293),2/371,0.1004316930978611,0.2250862008880022,0,0,3.934959349593496,9.043628352554697,PTPRT;ITK
659,GO_Biological_Process_2017b,double-strand break repair via break-induced replication (GO:0000727),1/73,0.1006812312455331,0.2250862008880022,0,0,9.870535714285714,22.660735221252363,MCM9
660,GO_Biological_Process_2017b,positive regulation of autophagy of mitochondrion (GO:1903599),1/73,0.1006812312455331,0.2250862008880022,0,0,9.870535714285714,22.660735221252363,PRKN
661,GO_Biological_Process_2017b,negative regulation of autophagy (GO:0010507),1/73,0.1006812312455331,0.2250862008880022,0,0,9.870535714285714,22.660735221252363,PRKN
662,GO_Biological_Process_2017b,negative regulation of I-kappaB phosphorylation (GO:1903720),1/73,0.1006812312455331,0.2250862008880022,0,0,9.870535714285714,22.660735221252363,PRKN
649,GO_Biological_Process_2017b,negative regulation of neuron death (GO:1901215),1/71,0.0980581297624673,0.2250862008880022,0,0,10.153571428571428,23.578570928414106,PRKN
648,GO_Biological_Process_2017b,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912),1/70,0.0967438103878096,0.2250862008880022,0,0,10.301242236024844,24.06049739864184,PRKN
673,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment (GO:0021899),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,FRS3
684,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow (GO:0035602),1/78,0.1072068007866111,0.2254240297621175,0,0,9.227272727272728,20.60445932788025,FRS3
683,GO_Biological_Process_2017b,negative regulation of insulin secretion (GO:0046676),1/78,0.1072068007866111,0.2254240297621175,0,0,9.227272727272728,20.60445932788025,PRKN
682,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in forebrain neuroblast division (GO:0021875),1/78,0.1072068007866111,0.2254240297621175,0,0,9.227272727272728,20.60445932788025,FRS3
681,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604),1/78,0.1072068007866111,0.2254240297621175,0,0,9.227272727272728,20.60445932788025,FRS3
680,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000699),1/78,0.1072068007866111,0.2254240297621175,0,0,9.227272727272728,20.60445932788025,FRS3
679,GO_Biological_Process_2017b,mitochondrial respiratory chain supercomplex assembly (GO:0097250),1/78,0.1072068007866111,0.2254240297621175,0,0,9.227272727272728,20.60445932788025,PRKN
678,GO_Biological_Process_2017b,positive regulation of autophagy (GO:0010508),1/78,0.1072068007866111,0.2254240297621175,0,0,9.227272727272728,20.60445932788025,PRKN
674,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in heart induction (GO:0003135),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,FRS3
676,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,FRS3
677,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in somitogenesis (GO:0090243),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,FRS3
664,GO_Biological_Process_2017b,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),1/74,0.101990018350818,0.2254240297621175,0,0,9.734833659491194,22.22346027505055,PRKN
665,GO_Biological_Process_2017b,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/75,0.1032969663744447,0.2254240297621175,0,0,9.602799227799228,21.799768455453663,PRKN
666,GO_Biological_Process_2017b,epidermis morphogenesis (GO:0048730),1/75,0.1032969663744447,0.2254240297621175,0,0,9.602799227799228,21.799768455453663,EDAR
667,GO_Biological_Process_2017b,negative regulation of protein phosphorylation (GO:0001933),1/76,0.1046020777922812,0.2254240297621175,0,0,9.474285714285717,21.3890703398866,PRKN
668,GO_Biological_Process_2017b,cellular process regulating host cell cycle in response to virus (GO:0060154),1/76,0.1046020777922812,0.2254240297621175,0,0,9.474285714285717,21.3890703398866,CDC25A
675,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in lung induction (GO:0060499),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,FRS3
670,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,FRS3
671,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in heart development (GO:0061313),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,FRS3
672,GO_Biological_Process_2017b,regulation of autophagy of mitochondrion (GO:1903146),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,PRKN
663,GO_Biological_Process_2017b,mitochondrial calcium ion homeostasis (GO:0051560),1/74,0.101990018350818,0.2254240297621175,0,0,9.734833659491194,22.22346027505055,MAIP1
669,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in spinal cord anterior/posterior pattern formation (GO:0021907),1/77,0.1059053551062263,0.2254240297621175,0,0,9.349154135338344,20.99080930838857,FRS3
685,GO_Biological_Process_2017b,mitochondrial protein catabolic process (GO:0035694),1/79,0.1085064173227218,0.2263216961851945,0,0,9.108516483516484,20.22952290313978,PRKN
686,GO_Biological_Process_2017b,mitochondrial fission (GO:0000266),1/79,0.1085064173227218,0.2263216961851945,0,0,9.108516483516484,20.22952290313978,PRKN
687,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060825),1/79,0.1085064173227218,0.2263216961851945,0,0,9.108516483516484,20.22952290313978,FRS3
221,GO_Biological_Process_2018,regulation of vesicle-mediated transport (GO:0060627),1/138,0.1820337587742559,0.2271322125246346,0,0,5.170490093847758,8.808256243109229,PRKN
688,GO_Biological_Process_2017b,ERAD pathway (GO:0036503),1/80,0.109804207201114,0.2284162385092693,0,0,8.992766726943943,19.865529194835588,PRKN
223,GO_Biological_Process_2018,modification-dependent protein catabolic process (GO:0019941),1/141,0.1856115798261867,0.2295286054100613,0,0,5.058928571428571,8.519736898653388,PRKN
222,GO_Biological_Process_2018,double-strand break repair (GO:0006302),1/141,0.1856115798261867,0.2295286054100613,0,0,5.058928571428571,8.519736898653388,MCM9
689,GO_Biological_Process_2017b,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/81,0.1111001728834724,0.2298828045301637,0,0,8.879910714285714,19.512032283374484,CDC25A
690,GO_Biological_Process_2017b,O-glycan processing (GO:0016266),1/81,0.1111001728834724,0.2298828045301637,0,0,8.879910714285714,19.512032283374484,LARGE1
224,GO_Biological_Process_2018,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/142,0.1868008255388087,0.2299725718855556,0,0,5.022796352583587,8.42680739101831,PTPRT
691,GO_Biological_Process_2017b,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/82,0.112394316840881,0.2313301018576863,0,0,8.76984126984127,19.16860956118856,CDC25A
692,GO_Biological_Process_2017b,mitochondrial respiratory chain complex assembly (GO:0033108),1/82,0.112394316840881,0.2313301018576863,0,0,8.76984126984127,19.16860956118856,PRKN
694,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.1136866415597872,0.2321475252848148,0,0,8.662456445993032,18.834860248996137,PTPRT
693,GO_Biological_Process_2017b,positive regulation of chaperone-mediated autophagy (GO:1904716),1/83,0.1136866415597872,0.2321475252848148,0,0,8.662456445993032,18.834860248996137,PRKN
695,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.1136866415597872,0.2321475252848148,0,0,8.662456445993032,18.834860248996137,PTPRT
696,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.1149771494929438,0.2335567162023768,0,0,8.557659208261619,18.5104040271028,PTPRT
697,GO_Biological_Process_2017b,positive regulation of posterior neural plate formation by fibroblast growth factor receptor signaling pathway (GO:0060787),1/84,0.1149771494929438,0.2335567162023768,0,0,8.557659208261619,18.5104040271028,FRS3
698,GO_Biological_Process_2017b,positive regulation of cell cycle (GO:0045787),1/86,0.117552724870697,0.2375481037646812,0,0,8.35546218487395,17.887944321802927,CDC25A
699,GO_Biological_Process_2017b,DNA synthesis involved in double-strand break repair via homologous recombination (GO:0043150),1/86,0.117552724870697,0.2375481037646812,0,0,8.35546218487395,17.887944321802927,MCM9
225,GO_Biological_Process_2018,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/148,0.1939011657318861,0.2376576234855418,0,0,4.816326530612245,7.900734332963019,PRKN
700,GO_Biological_Process_2017b,negative regulation of MAPK cascade (GO:0043409),1/87,0.1188377972199883,0.2395228140858833,0,0,8.257890365448505,17.589271499945774,PRKN
226,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),2/565,0.1971151691187381,0.2405326072506187,0,0,2.5535162160384184,4.14682634011952,PRKN;GLIS3
227,GO_Biological_Process_2018,protein stabilization (GO:0050821),1/152,0.1986014313227411,0.2412833178789442,0,0,4.687795648060549,7.577612215945519,PRKN
701,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.1201210626217972,0.2414836866143624,0,0,8.16256157635468,17.298550980881092,PTPRT
702,GO_Biological_Process_2017b,positive regulation of protein import into mitochondrial outer membrane (GO:1903638),1/89,0.1214025235104908,0.2428050470209817,0,0,8.06939935064935,17.015487408196194,PRKN
703,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.1214025235104908,0.2428050470209817,0,0,8.06939935064935,17.015487408196194,PTPRT
705,GO_Biological_Process_2017b,G1/S transition of mitotic cell cycle (GO:0000082),1/91,0.1239600415911738,0.2454249084345169,0,0,7.889285714285714,16.47121924030951,CDC25A
706,GO_Biological_Process_2017b,selective autophagy (GO:0061912),1/91,0.1239600415911738,0.2454249084345169,0,0,7.889285714285714,16.47121924030951,PRKN
707,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.1252361036613152,0.2454249084345169,0,0,7.802197802197802,16.209491106910413,PTPRT
704,GO_Biological_Process_2017b,macroautophagy (GO:0016236),1/91,0.1239600415911738,0.2454249084345169,0,0,7.889285714285714,16.47121924030951,PRKN
710,GO_Biological_Process_2017b,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/92,0.1252361036613152,0.2454249084345169,0,0,7.802197802197802,16.209491106910413,CDC25A
709,GO_Biological_Process_2017b,regulation of mitotic cell cycle (GO:0007346),1/92,0.1252361036613152,0.2454249084345169,0,0,7.802197802197802,16.209491106910413,CDC25A
708,GO_Biological_Process_2017b,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/92,0.1252361036613152,0.2454249084345169,0,0,7.802197802197802,16.209491106910413,PRKN
711,GO_Biological_Process_2017b,negative regulation of cell cycle (GO:0045786),1/92,0.1252361036613152,0.2454249084345169,0,0,7.802197802197802,16.209491106910413,CDC25A
712,GO_Biological_Process_2017b,autophagosome organization (GO:1905037),1/93,0.1265103709770979,0.2472991673873925,0,0,7.717003105590062,15.954371371707152,PRKN
713,GO_Biological_Process_2017b,skin epidermis development (GO:0098773),1/94,0.1277828460126215,0.2491405639255675,0,0,7.633640552995391,15.705627428388125,EDAR
714,GO_Biological_Process_2017b,ventral cord development (GO:0007419),1/95,0.1290535311850947,0.2491405639255675,0,0,7.552051671732523,15.463037181836098,PRKN
715,GO_Biological_Process_2017b,central nervous system maturation (GO:0021626),1/95,0.1290535311850947,0.2491405639255675,0,0,7.552051671732523,15.463037181836098,PRKN
716,GO_Biological_Process_2017b,larval central nervous system remodeling (GO:0035193),1/95,0.1290535311850947,0.2491405639255675,0,0,7.552051671732523,15.463037181836098,PRKN
717,GO_Biological_Process_2017b,central nervous system segmentation (GO:0035283),1/95,0.1290535311850947,0.2491405639255675,0,0,7.552051671732523,15.463037181836098,PRKN
718,GO_Biological_Process_2017b,preganglionic parasympathetic fiber development (GO:0021783),1/96,0.1303224289056154,0.2509674497241803,0,0,7.472180451127819,15.226388466574354,PRKN
723,GO_Biological_Process_2017b,negative regulation of production of siRNA involved in RNA interference (GO:1903704),1/98,0.132854871702785,0.2514868374325226,0,0,7.317378497790869,14.77011340018396,PRKN
725,GO_Biological_Process_2017b,suppression by virus of host gene expression (GO:0039657),1/98,0.132854871702785,0.2514868374325226,0,0,7.317378497790869,14.77011340018396,PRKN
724,GO_Biological_Process_2017b,negative regulation of histone gene expression (GO:0036208),1/98,0.132854871702785,0.2514868374325226,0,0,7.317378497790869,14.77011340018396,PRKN
721,GO_Biological_Process_2017b,negative regulation of snoRNA processing (GO:1902797),1/98,0.132854871702785,0.2514868374325226,0,0,7.317378497790869,14.77011340018396,PRKN
720,GO_Biological_Process_2017b,negative regulation of tRNA processing (GO:2000236),1/98,0.132854871702785,0.2514868374325226,0,0,7.317378497790869,14.77011340018396,PRKN
719,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.1315895416100669,0.2514868374325226,0,0,7.393973214285714,14.995478504149393,PTPRT
722,GO_Biological_Process_2017b,negative regulation of protein maturation (GO:1903318),1/98,0.132854871702785,0.2514868374325226,0,0,7.317378497790869,14.77011340018396,PRKN
726,GO_Biological_Process_2017b,negative regulation of rhodopsin gene expression (GO:0045871),1/99,0.1341184216510177,0.2532624564186694,0,0,7.24234693877551,14.55010766501914,PRKN
727,GO_Biological_Process_2017b,glycosphingolipid biosynthetic process (GO:0006688),1/100,0.13538019382269,0.2550261278306364,0,0,7.1688311688311686,14.335283778329618,LARGE1
744,GO_Biological_Process_2017b,establishment of endothelial blood-brain barrier (GO:0014045),1/112,0.1503836692132686,0.255193813011887,0,0,6.38996138996139,12.10620011280844,PRKN
745,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603),1/112,0.1503836692132686,0.255193813011887,0,0,6.38996138996139,12.10620011280844,FRS3
746,GO_Biological_Process_2017b,positive regulation of protein targeting to mitochondrion (GO:1903955),1/113,0.1516225488163737,0.255193813011887,0,0,6.332589285714286,11.945549951152008,PRKN
736,GO_Biological_Process_2017b,replication of extrachromosomal circular DNA (GO:0001326),1/106,0.1429136286904141,0.255193813011887,0,0,6.757142857142857,13.146121612489974,CDC25A
747,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
743,GO_Biological_Process_2017b,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777),1/112,0.1503836692132686,0.255193813011887,0,0,6.38996138996139,12.10620011280844,PRKN
777,GO_Biological_Process_2017b,negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),2/484,0.1550450254875001,0.255193813011887,0,0,2.995082219148609,5.58295221286221,PRKN;GLIS3
741,GO_Biological_Process_2017b,microglia differentiation (GO:0014004),1/110,0.1479006676495557,0.255193813011887,0,0,6.507863695937091,12.43792277689215,PRKN
740,GO_Biological_Process_2017b,double-strand break repair via homologous recombination (GO:0000724),1/110,0.1479006676495557,0.255193813011887,0,0,6.507863695937091,12.43792277689215,MCM9
739,GO_Biological_Process_2017b,mitochondrial fusion (GO:0008053),1/109,0.1466565409888442,0.255193813011887,0,0,6.568452380952381,12.60920765835375,PRKN
738,GO_Biological_Process_2017b,DNA synthesis involved in DNA replication (GO:0090592),1/108,0.1454106605065873,0.255193813011887,0,0,6.630173564753004,12.784256895768596,CDC25A
737,GO_Biological_Process_2017b,negative regulation of mRNA processing (GO:0050686),1/108,0.1454106605065873,0.255193813011887,0,0,6.630173564753004,12.784256895768596,PRKN
748,GO_Biological_Process_2017b,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
776,GO_Biological_Process_2017b,negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490),2/483,0.1545378124578967,0.255193813011887,0,0,3.001463001463001,5.6046813020121045,PRKN;GLIS3
749,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
751,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
803,GO_Biological_Process_2017b,regulation of fibroblast proliferation (GO:0048145),1/122,0.1626942561104061,0.255193813011887,0,0,5.858913813459268,10.639099466798154,ITK
802,GO_Biological_Process_2017b,regulation of sebum secreting cell proliferation (GO:1904002),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
801,GO_Biological_Process_2017b,regulation of mammary stem cell proliferation (GO:2000101),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
800,GO_Biological_Process_2017b,regulation of cell proliferation in bone marrow (GO:0071863),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
799,GO_Biological_Process_2017b,regulation of skeletal muscle cell proliferation (GO:0014857),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
798,GO_Biological_Process_2017b,regulation of glial cell proliferation (GO:0060251),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
797,GO_Biological_Process_2017b,regulation of leukocyte proliferation (GO:0070663),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
796,GO_Biological_Process_2017b,regulation of mesenchymal cell proliferation (GO:0010464),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
795,GO_Biological_Process_2017b,regulation of germ cell proliferation (GO:1905936),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
794,GO_Biological_Process_2017b,regulation of fat cell proliferation (GO:0070344),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
793,GO_Biological_Process_2017b,regulation of hair follicle cell proliferation (GO:0071336),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
792,GO_Biological_Process_2017b,regulation of synoviocyte proliferation (GO:1901645),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
804,GO_Biological_Process_2017b,regulation of cell proliferation involved in tissue homeostasis (GO:0060784),1/122,0.1626942561104061,0.255193813011887,0,0,5.858913813459268,10.639099466798154,ITK
791,GO_Biological_Process_2017b,regulation of cell proliferation involved in kidney development (GO:1901722),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
789,GO_Biological_Process_2017b,regulation of hemocyte proliferation (GO:0035206),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
788,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),2/496,0.161158085409103,0.255193813011887,0,0,2.920527815264657,5.331042394358358,PRKN;GLIS3
787,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489),2/492,0.1591150555996858,0.255193813011887,0,0,2.944973544973545,5.413237502749425,PRKN;GLIS3
786,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387),2/491,0.1586051217295092,0.255193813011887,0,0,2.95114746648489,5.434059020204318,PRKN;GLIS3
785,GO_Biological_Process_2017b,DNA-dependent DNA replication (GO:0006261),1/118,0.157790829920516,0.255193813011887,0,0,6.06043956043956,11.190510646586436,CDC25A
784,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),2/488,0.1570773275482427,0.255193813011887,0,0,2.9698216735253773,5.4971905909714245,PRKN;GLIS3
783,GO_Biological_Process_2017b,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),2/487,0.1565687384658785,0.255193813011887,0,0,2.976097747231768,5.518459431412137,PRKN;GLIS3
782,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),2/485,0.155552585484849,0.255193813011887,0,0,2.988727858293076,5.561339423336312,PRKN;GLIS3
781,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),2/484,0.1550450254875001,0.255193813011887,0,0,2.995082219148609,5.58295221286221,PRKN;GLIS3
780,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949),2/484,0.1550450254875001,0.255193813011887,0,0,2.995082219148609,5.58295221286221,PRKN;GLIS3
779,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427),2/484,0.1550450254875001,0.255193813011887,0,0,2.995082219148609,5.58295221286221,PRKN;GLIS3
778,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),2/484,0.1550450254875001,0.255193813011887,0,0,2.995082219148609,5.58295221286221,PRKN;GLIS3
790,GO_Biological_Process_2017b,regulation of cell proliferation (GO:0042127),1/121,0.1614709900485726,0.255193813011887,0,0,5.908035714285714,10.772888266493863,ITK
805,GO_Biological_Process_2017b,regulation of cell proliferation involved in imaginal disc-derived wing morphogenesis (GO:0090256),1/122,0.1626942561104061,0.255193813011887,0,0,5.858913813459268,10.639099466798154,ITK
806,GO_Biological_Process_2017b,regulation of chorionic trophoblast cell proliferation (GO:1901382),1/122,0.1626942561104061,0.255193813011887,0,0,5.858913813459268,10.639099466798154,ITK
807,GO_Biological_Process_2017b,regulation of cell proliferation involved in heart morphogenesis (GO:2000136),1/122,0.1626942561104061,0.255193813011887,0,0,5.858913813459268,10.639099466798154,ITK
752,GO_Biological_Process_2017b,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
753,GO_Biological_Process_2017b,negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
754,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
755,GO_Biological_Process_2017b,regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
756,GO_Biological_Process_2017b,negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
757,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
758,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
759,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
760,GO_Biological_Process_2017b,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
761,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
762,GO_Biological_Process_2017b,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
764,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
765,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
766,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
767,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
768,GO_Biological_Process_2017b,transfer RNA gene-mediated silencing (GO:0061587),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
769,GO_Biological_Process_2017b,negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
770,GO_Biological_Process_2017b,negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
742,GO_Biological_Process_2017b,regulation of macroautophagy (GO:0016241),1/110,0.1479006676495557,0.255193813011887,0,0,6.507863695937091,12.43792277689215,PRKN
771,GO_Biological_Process_2017b,negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471),2/482,0.1540309483836408,0.255193813011887,0,0,3.0078703703703704,5.626527528142482,PRKN;GLIS3
772,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070),2/482,0.1540309483836408,0.255193813011887,0,0,3.0078703703703704,5.626527528142482,PRKN;GLIS3
773,GO_Biological_Process_2017b,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),2/482,0.1540309483836408,0.255193813011887,0,0,3.0078703703703704,5.626527528142482,PRKN;GLIS3
774,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758),2/482,0.1540309483836408,0.255193813011887,0,0,3.0078703703703704,5.626527528142482,PRKN;GLIS3
775,GO_Biological_Process_2017b,TNFSF11-mediated signaling pathway (GO:0071847),1/115,0.1540950775438487,0.255193813011887,0,0,6.220864661654136,11.63417076591374,EDAR
810,GO_Biological_Process_2017b,regulation of epithelial cell proliferation (GO:0050678),1/122,0.1626942561104061,0.255193813011887,0,0,5.858913813459268,10.639099466798154,ITK
809,GO_Biological_Process_2017b,regulation of cell proliferation involved in compound eye morphogenesis (GO:2000495),1/122,0.1626942561104061,0.255193813011887,0,0,5.858913813459268,10.639099466798154,ITK
808,GO_Biological_Process_2017b,protein glycosylation (GO:0006486),1/122,0.1626942561104061,0.255193813011887,0,0,5.858913813459268,10.639099466798154,LARGE1
750,GO_Biological_Process_2017b,negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
735,GO_Biological_Process_2017b,fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178),1/106,0.1429136286904141,0.255193813011887,0,0,6.757142857142857,13.146121612489974,FRS3
763,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463),2/481,0.1535244351837998,0.255193813011887,0,0,3.0143044923838245,5.648491737723825,PRKN;GLIS3
733,GO_Biological_Process_2017b,spinal cord development (GO:0021510),1/104,0.1404095530685888,0.255193813011887,0,0,6.889042995839112,13.524512360401651,PRKN
732,GO_Biological_Process_2017b,oligodendrocyte differentiation (GO:0048709),1/104,0.1404095530685888,0.255193813011887,0,0,6.889042995839112,13.524512360401651,PRKN
731,GO_Biological_Process_2017b,astrocyte differentiation (GO:0048708),1/103,0.1391548678538364,0.255193813011887,0,0,6.956932773109243,13.720238863404822,PRKN
730,GO_Biological_Process_2017b,autophagosome maturation (GO:0097352),1/103,0.1391548678538364,0.255193813011887,0,0,6.956932773109243,13.720238863404822,PRKN
729,GO_Biological_Process_2017b,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/103,0.1391548678538364,0.255193813011887,0,0,6.956932773109243,13.720238863404822,PRKN
728,GO_Biological_Process_2017b,negative regulation of rRNA processing (GO:2000233),1/101,0.1366401906284411,0.255193813011887,0,0,7.096785714285715,14.125471764544198,PRKN
734,GO_Biological_Process_2017b,positive regulation of JUN kinase activity (GO:0043507),1/106,0.1429136286904141,0.255193813011887,0,0,6.757142857142857,13.146121612489974,EDAR
813,GO_Biological_Process_2017b,regulation of cardiac muscle cell proliferation (GO:0060043),1/123,0.1639157991027448,0.2555641116271252,0,0,5.81059718969555,10.507897921340264,ITK
812,GO_Biological_Process_2017b,regulation of neural precursor cell proliferation (GO:2000177),1/123,0.1639157991027448,0.2555641116271252,0,0,5.81059718969555,10.507897921340264,ITK
811,GO_Biological_Process_2017b,regulation of myoblast proliferation (GO:2000291),1/123,0.1639157991027448,0.2555641116271252,0,0,5.81059718969555,10.507897921340264,ITK
228,GO_Biological_Process_2018,T cell receptor signaling pathway (GO:0050852),1/163,0.2113911233802811,0.2557001798093357,0,0,4.367063492063492,6.78661404096635,ITK
816,GO_Biological_Process_2017b,regulation of osteoblast proliferation (GO:0033688),1/124,0.1651356213455527,0.255927317543506,0,0,5.7630662020905925,10.379214197813798,ITK
815,GO_Biological_Process_2017b,epidermal cell differentiation (GO:0009913),1/124,0.1651356213455527,0.255927317543506,0,0,5.7630662020905925,10.379214197813798,EDAR
814,GO_Biological_Process_2017b,regulation of cell proliferation involved in kidney morphogenesis (GO:0061006),1/124,0.1651356213455527,0.255927317543506,0,0,5.7630662020905925,10.379214197813798,ITK
818,GO_Biological_Process_2017b,regulation of stem cell proliferation (GO:0072091),1/125,0.1663537252021877,0.2567920599351231,0,0,5.716301843317972,10.25298125318036,ITK
817,GO_Biological_Process_2017b,DNA replication (GO:0006260),1/125,0.1663537252021877,0.2567920599351231,0,0,5.716301843317972,10.25298125318036,CDC25A
819,GO_Biological_Process_2017b,regulation of growth plate cartilage chondrocyte proliferation (GO:0003420),1/126,0.1675701129945591,0.2581575206134,0,0,5.670285714285714,10.129134336252406,ITK
821,GO_Biological_Process_2017b,regulation of cell proliferation involved in embryonic placenta development (GO:0060723),1/127,0.1687847870526419,0.2584932368640854,0,0,5.625,10.007610890498013,ITK
820,GO_Biological_Process_2017b,regulation of trophectodermal cell proliferation (GO:1904073),1/127,0.1687847870526419,0.2584932368640854,0,0,5.625,10.007610890498013,ITK
822,GO_Biological_Process_2017b,regulation of smooth muscle cell proliferation (GO:0048660),1/127,0.1687847870526419,0.2584932368640854,0,0,5.625,10.007610890498013,ITK
229,GO_Biological_Process_2018,mitochondrion organization (GO:0007005),1/167,0.2159928767974763,0.2601305516213084,0,0,4.260972461273666,6.529982265909244,PRKN
824,GO_Biological_Process_2017b,negative regulation of RNA splicing (GO:0033119),1/129,0.1712090032573018,0.2611776559493741,0,0,5.536551339285714,9.771294621938235,PRKN
823,GO_Biological_Process_2017b,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080),1/129,0.1712090032573018,0.2611776559493741,0,0,5.536551339285714,9.771294621938235,FRS3
825,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),3/991,0.1717649954485169,0.2615130459079181,0,0,2.216949548427281,3.9054404920913264,ATF7IP;PRKN;GLIS3
826,GO_Biological_Process_2017b,G2/M transition of mitotic cell cycle (GO:0000086),1/130,0.1724185500532113,0.2619953748855437,0,0,5.493355481727575,9.65638686620222,CDC25A
230,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",3/1120,0.2198324572475638,0.2636086175652605,0,0,1.947593140968253,2.950388556750073,ATF7IP;PRKN;GLIS3
827,GO_Biological_Process_2017b,mRNA catabolic process (GO:0006402),1/132,0.1748325326296758,0.265145634280483,0,0,5.408942202835332,9.43279883248906,PRKN
828,GO_Biological_Process_2017b,"negative regulation of gene expression, epigenetic (GO:0045814)",1/133,0.1760369730652206,0.2664528502815986,0,0,5.367694805194805,9.324014550089352,PRKN
231,GO_Biological_Process_2018,negative regulation of Wnt signaling pathway (GO:0030178),1/174,0.2239836316766645,0.2668423572223424,0,0,4.087118084227911,6.115073746540567,PRKN
232,GO_Biological_Process_2018,protein autophosphorylation (GO:0046777),1/175,0.2251187291557794,0.2668423572223424,0,0,4.063423645320197,6.059082054228087,ITK
233,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),2/618,0.225419175415264,0.2668423572223424,0,0,2.3274410774410774,3.46740684055864,ATF7IP;PRKN
234,GO_Biological_Process_2018,negative regulation of protein phosphorylation (GO:0001933),1/178,0.2285144113270738,0.2693552848408487,0,0,3.993946731234866,5.8956884364707,PRKN
235,GO_Biological_Process_2018,organonitrogen compound biosynthetic process (GO:1901566),1/181,0.2318957239165233,0.2721826929020209,0,0,3.9267857142857134,5.738869599711159,LARGE1
236,GO_Biological_Process_2018,Fc-epsilon receptor signaling pathway (GO:0038095),1/182,0.2330196449858118,0.2723478551099994,0,0,3.904893449092344,5.6879947683963685,ITK
237,GO_Biological_Process_2018,Fc receptor signaling pathway (GO:0038093),1/183,0.2341419781492404,0.2725097812913428,0,0,3.883241758241758,5.637797575258975,ITK
829,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089),2/534,0.1808082203878643,0.2731432921587542,0,0,2.706627680311891,4.6291950296954685,PRKN;GLIS3
832,GO_Biological_Process_2017b,autophagosome-lysosome fusion (GO:0061909),1/138,0.1820337587742559,0.2734020546841141,0,0,5.170490093847758,8.808256243109229,PRKN
830,GO_Biological_Process_2017b,amphisome-lysosome fusion (GO:0061911),1/138,0.1820337587742559,0.2734020546841141,0,0,5.170490093847758,8.808256243109229,PRKN
831,GO_Biological_Process_2017b,autophagosome-endosome fusion (GO:0061910),1/138,0.1820337587742559,0.2734020546841141,0,0,5.170490093847758,8.808256243109229,PRKN
835,GO_Biological_Process_2017b,T cell receptor signaling pathway (GO:0050852),1/141,0.1856115798261867,0.276639481043627,0,0,5.058928571428571,8.519736898653388,ITK
834,GO_Biological_Process_2017b,negative regulation of protein kinase activity (GO:0006469),1/141,0.1856115798261867,0.276639481043627,0,0,5.058928571428571,8.519736898653388,PRKN
833,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/141,0.1856115798261867,0.276639481043627,0,0,5.058928571428571,8.519736898653388,PRKN
836,GO_Biological_Process_2017b,protein stabilization (GO:0050821),1/141,0.1856115798261867,0.276639481043627,0,0,5.058928571428571,8.519736898653388,PRKN
837,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067),1/142,0.1868008255388087,0.2768210328937012,0,0,5.022796352583587,8.42680739101831,PRKN
838,GO_Biological_Process_2017b,regulation of mRNA stability involved in cellular response to UV (GO:1902629),1/142,0.1868008255388087,0.2768210328937012,0,0,5.022796352583587,8.42680739101831,CDC25A
839,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0072336),1/142,0.1868008255388087,0.2768210328937012,0,0,5.022796352583587,8.42680739101831,PRKN
840,GO_Biological_Process_2017b,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082),1/143,0.1879883944003141,0.2775236638395529,0,0,4.987173038229376,8.335436585984167,PRKN
841,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829),1/143,0.1879883944003141,0.2775236638395529,0,0,4.987173038229376,8.335436585984167,PRKN
238,GO_Biological_Process_2018,RNA metabolic process (GO:0016070),1/191,0.2430637365844259,0.2817098536982677,0,0,3.718233082706767,5.25918629235571,LRPPRC
239,GO_Biological_Process_2018,cellular response to tumor necrosis factor (GO:0071356),1/194,0.2463834556022868,0.284367571674306,0,0,3.659881569207994,5.127004364523929,EDAR
842,GO_Biological_Process_2017b,termination of T cell signal transduction (GO:0023022),1/150,0.1962546159004851,0.2891782029745784,0,0,4.751198465963567,7.736577922845861,ITK
843,GO_Biological_Process_2017b,positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway (GO:1902844),1/151,0.1974288518264551,0.2903585004177355,0,0,4.719285714285714,7.656460615619498,PRKN
844,GO_Biological_Process_2017b,protein targeting to mitochondrion (GO:0006626),1/152,0.1986014313227411,0.2915319123945143,0,0,4.687795648060549,7.577612215945519,PRKN
240,GO_Biological_Process_2018,regulation of autophagy (GO:0010506),1/203,0.256258485189531,0.2945377609854775,0,0,3.4952263083451203,4.758990517664546,PRKN
845,GO_Biological_Process_2017b,UV-damage excision repair (GO:0070914),1/158,0.2056022491071387,0.3012402067897437,0,0,4.507279344858962,7.1296676816470494,CDC25A
846,GO_Biological_Process_2017b,central nervous system neuron differentiation (GO:0021953),1/159,0.206763296473957,0.302371888452516,0,0,4.478526220614828,7.058966303621936,PRKN
241,GO_Biological_Process_2018,regulation of canonical Wnt signaling pathway (GO:0060828),1/213,0.2670842108208054,0.3057120925510873,0,0,3.3286725067385445,4.394484397320879,PRKN
242,GO_Biological_Process_2018,regulation of cell cycle (GO:0051726),1/215,0.2692310230932951,0.3069012073944147,0,0,3.297229639519359,4.326576745257571,CDC25A
243,GO_Biological_Process_2018,central nervous system development (GO:0007417),1/217,0.271371763278782,0.3080736820828796,0,0,3.2663690476190474,4.260212713760186,PRKN
847,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240),1/164,0.2125440005707,0.3102424623714908,0,0,4.340052585451359,6.721032561514259,PRKN
244,GO_Biological_Process_2018,mitotic cell cycle phase transition (GO:0044772),1/221,0.2756350936135662,0.3116364119630933,0,0,3.2063311688311686,4.131926554688627,CDC25A
848,GO_Biological_Process_2017b,negative regulation of translation (GO:0017148),1/166,0.2148448750482433,0.3130136943586766,0,0,4.287012987012987,6.59273586213286,PRKN
849,GO_Biological_Process_2017b,negative regulation of gene expression (GO:0010629),1/169,0.2182840202559386,0.3174298462787294,0,0,4.209821428571429,6.407172323520683,PRKN
277,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0328410113902878,0.3205428755914956,0,0,32.38474025974026,110.62877274373584,LARGE1
288,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.2136952503943304,0.3205428755914956,0,0,4.3133710801393725,6.656412981600426,PRKN
287,KEGG_2019_Human,Cellular senescence,1/160,0.2079227053717385,0.3205428755914956,0,0,4.450134770889488,6.989332172907156,CDC25A
282,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.1366401906284411,0.3205428755914956,0,0,7.096785714285715,14.125471764544198,ITK
285,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.1808377828071115,0.3205428755914956,0,0,5.208771008403361,8.907805143996194,PRKN
284,KEGG_2019_Human,Cell cycle,1/124,0.1651356213455527,0.3205428755914956,0,0,5.7630662020905925,10.379214197813798,CDC25A
283,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.1503836692132686,0.3205428755914956,0,0,6.38996138996139,12.10620011280844,ITK
281,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.1341184216510177,0.3205428755914956,0,0,7.24234693877551,14.55010766501914,CDC25A
280,KEGG_2019_Human,Protein digestion and absorption,1/90,0.1226821823509282,0.3205428755914956,0,0,7.978330658105939,16.73979950106851,COL6A5
278,KEGG_2019_Human,Mitophagy,1/65,0.090144426983272,0.3205428755914956,0,0,11.108816964285714,26.73161450467769,PRKN
279,KEGG_2019_Human,ECM-receptor interaction,1/82,0.112394316840881,0.3205428755914956,0,0,8.76984126984127,19.16860956118856,COL6A5
286,KEGG_2019_Human,Parkinson disease,1/142,0.1868008255388087,0.3205428755914956,0,0,5.022796352583587,8.42680739101831,PRKN
289,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.2419540293246899,0.3238522787485048,0,0,3.738095238095238,5.3043852994563405,ITK
290,KEGG_2019_Human,Focal adhesion,1/199,0.2518851056932815,0.3238522787485048,0,0,3.566558441558441,4.917507384453618,COL6A5
850,GO_Biological_Process_2017b,brain development (GO:0007420),1/174,0.2239836316766645,0.3251105698590392,0,0,4.087118084227911,6.115073746540567,PRKN
245,GO_Biological_Process_2018,proteasomal protein catabolic process (GO:0010498),1/237,0.292448822460311,0.329302129355716,0,0,2.9865314769975786,3.671837695070991,PRKN
851,GO_Biological_Process_2017b,peptidyl-tyrosine autophosphorylation (GO:0038083),1/178,0.2285144113270738,0.3310692961125948,0,0,3.993946731234866,5.8956884364707,ITK
852,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/179,0.2296431092465047,0.3320861319587002,0,0,3.971308186195827,5.842703271555632,PRKN
855,GO_Biological_Process_2017b,histone H3-K56 acetylation in response to DNA damage (GO:0097044),1/182,0.2330196449858118,0.3344820734298184,0,0,3.904893449092344,5.6879947683963685,MCM9
856,GO_Biological_Process_2017b,cellular response to DNA damage stimulus (GO:0006974),1/182,0.2330196449858118,0.3344820734298184,0,0,3.904893449092344,5.6879947683963685,MCM9
853,GO_Biological_Process_2017b,SOS response (GO:0009432),1/182,0.2330196449858118,0.3344820734298184,0,0,3.904893449092344,5.6879947683963685,MCM9
854,GO_Biological_Process_2017b,Fc-epsilon receptor signaling pathway (GO:0038095),1/182,0.2330196449858118,0.3344820734298184,0,0,3.904893449092344,5.6879947683963685,ITK
857,GO_Biological_Process_2017b,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097),1/183,0.2341419781492404,0.3348574613972592,0,0,3.883241758241758,5.637797575258975,ITK
858,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248),1/183,0.2341419781492404,0.3348574613972592,0,0,3.883241758241758,5.637797575258975,MCM9
859,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.2374994715964886,0.3384933984624779,0,0,3.81969111969112,5.491149299794909,PTPRT
860,GO_Biological_Process_2017b,rRNA modification (GO:0000154),1/187,0.2386154746139523,0.3384933984624779,0,0,3.798963133640553,5.443541551248933,LRPPRC
863,GO_Biological_Process_2017b,ferredoxin metabolic process (GO:0006124),1/188,0.2397299004535029,0.3384933984624779,0,0,3.778456837280367,5.396552277337301,PRKN
862,GO_Biological_Process_2017b,rhodopsin metabolic process (GO:0046154),1/188,0.2397299004535029,0.3384933984624779,0,0,3.778456837280367,5.396552277337301,PRKN
864,GO_Biological_Process_2017b,prosthetic group metabolic process (GO:0051189),1/188,0.2397299004535029,0.3384933984624779,0,0,3.778456837280367,5.396552277337301,PRKN
865,GO_Biological_Process_2017b,cellular protein metabolic process (GO:0044267),1/188,0.2397299004535029,0.3384933984624779,0,0,3.778456837280367,5.396552277337301,PRKN
861,GO_Biological_Process_2017b,signal transduction in response to DNA damage (GO:0042770),1/188,0.2397299004535029,0.3384933984624779,0,0,3.778456837280367,5.396552277337301,MCM9
866,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),3/1175,0.2411959928105828,0.3399465260989737,0,0,1.8507810448936728,2.6320798008949957,ATF7IP;PRKN;GLIS3
867,GO_Biological_Process_2017b,protein denaturation involved in proteasomal ubiquitin-dependent protein catabolic process (GO:1902376),1/192,0.244171875318634,0.3428984097434969,0,0,3.698578908002992,5.214563136808866,PRKN
868,GO_Biological_Process_2017b,ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116),1/192,0.244171875318634,0.3428984097434969,0,0,3.698578908002992,5.214563136808866,PRKN
869,GO_Biological_Process_2017b,mitochondria-associated ubiquitin-dependent protein catabolic process (GO:0072671),1/193,0.2452784476136291,0.3438317698079341,0,0,3.6791294642857135,5.170505772822363,PRKN
870,GO_Biological_Process_2017b,transcription factor catabolic process (GO:0036369),1/194,0.2463834556022868,0.3441406255988853,0,0,3.659881569207994,5.127004364523929,PRKN
871,GO_Biological_Process_2017b,protein repair (GO:0030091),1/194,0.2463834556022868,0.3441406255988853,0,0,3.659881569207994,5.127004364523929,PRKN
872,GO_Biological_Process_2017b,ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596),1/195,0.2474869014244192,0.3450623822727565,0,0,3.640832106038292,5.084049294651244,PRKN
246,GO_Biological_Process_2018,positive regulation of gene expression (GO:0010628),2/771,0.3083717713870259,0.3458258326890939,0,0,1.8496363723931997,2.1760031824094934,ATF7IP;PRKN
873,GO_Biological_Process_2017b,CAAX-box protein maturation (GO:0080120),1/196,0.2485887872275552,0.345978669880211,0,0,3.621978021978022,5.041631158613987,PRKN
910,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903757),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
909,GO_Biological_Process_2017b,positive regulation of ergosterol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035961),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
908,GO_Biological_Process_2017b,positive regulation of pyrimidine-containing compound salvage by positive regulation of transcription from RNA polymerase II promoter (GO:1904001),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
905,GO_Biological_Process_2017b,transcriptional activation by promoter-terminator looping (GO:0090203),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
906,GO_Biological_Process_2017b,positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900422),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
911,GO_Biological_Process_2017b,positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter (GO:1900423),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
904,GO_Biological_Process_2017b,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
903,GO_Biological_Process_2017b,positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060963),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
902,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900622),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
907,GO_Biological_Process_2017b,positive regulation of starch catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035957),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
912,GO_Biological_Process_2017b,positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter (GO:1900524),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
915,GO_Biological_Process_2017b,positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter (GO:1900478),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
961,GO_Biological_Process_2017b,mitochondrial protein processing (GO:0034982),1/233,0.2882810679091747,0.3466501867594094,0,0,3.0386391625615765,3.779518171398918,PRKN
916,GO_Biological_Process_2017b,positive regulation of termination of RNA polymerase II transcription (GO:1904595),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
917,GO_Biological_Process_2017b,positive regulation of snRNA transcription from RNA polymerase II promoter (GO:1905382),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
919,GO_Biological_Process_2017b,positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900418),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
920,GO_Biological_Process_2017b,positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
921,GO_Biological_Process_2017b,positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter (GO:1900461),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
922,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in stress response to cadmium ion (GO:1902901),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
923,GO_Biological_Process_2017b,positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter (GO:0061424),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
924,GO_Biological_Process_2017b,positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0061425),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
925,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010673),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
913,GO_Biological_Process_2017b,positive regulation of sulfite transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061426),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
918,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
951,GO_Biological_Process_2017b,regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter (GO:0097301),2/728,0.2850317239614607,0.3466501867594094,0,0,1.9635751453933272,2.4645907546902435,PRKN;GLIS3
960,GO_Biological_Process_2017b,vacuolar protein processing (GO:0006624),1/233,0.2882810679091747,0.3466501867594094,0,0,3.0386391625615765,3.779518171398918,PRKN
937,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046022),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
938,GO_Biological_Process_2017b,positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900375),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
939,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/722,0.2817709081519411,0.3466501867594094,0,0,1.980555555555556,2.508692323389335,PRKN;GLIS3
940,GO_Biological_Process_2017b,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/227,0.2819849610474064,0.3466501867594094,0,0,3.120259165613148,3.949940880094462,PRKN
941,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter (GO:0035948),2/723,0.2823144048463872,0.3466501867594094,0,0,1.9777058612010068,2.5012716830672126,PRKN;GLIS3
942,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),2/724,0.2828578920277607,0.3466501867594094,0,0,1.974864060736637,2.493879379594222,PRKN;GLIS3
936,GO_Biological_Process_2017b,positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900413),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
943,GO_Biological_Process_2017b,SREBP signaling pathway (GO:0032933),2/725,0.2834013686152202,0.3466501867594094,0,0,1.9720301214077147,2.486515273320226,PRKN;GLIS3
945,GO_Biological_Process_2017b,positive regulation of central gap gene transcription (GO:0007357),2/725,0.2834013686152202,0.3466501867594094,0,0,1.9720301214077147,2.486515273320226,PRKN;GLIS3
946,GO_Biological_Process_2017b,positive regulation of SREBP signaling pathway (GO:2000640),2/725,0.2834013686152202,0.3466501867594094,0,0,1.9720301214077147,2.486515273320226,PRKN;GLIS3
947,GO_Biological_Process_2017b,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),2/725,0.2834013686152202,0.3466501867594094,0,0,1.9720301214077147,2.486515273320226,PRKN;GLIS3
948,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation (GO:0036278),2/725,0.2834013686152202,0.3466501867594094,0,0,1.9720301214077147,2.486515273320226,PRKN;GLIS3
949,GO_Biological_Process_2017b,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),2/726,0.2839448334976497,0.3466501867594094,0,0,1.969204010640475,2.479179225687413,PRKN;GLIS3
950,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),2/727,0.2844882856381281,0.3466501867594094,0,0,1.9663856960408683,2.47187109849788,PRKN;GLIS3
944,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),2/725,0.2834013686152202,0.3466501867594094,0,0,1.9720301214077147,2.486515273320226,PRKN;GLIS3
935,GO_Biological_Process_2017b,positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
934,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
933,GO_Biological_Process_2017b,positive regulation of posterior gap gene transcription (GO:0007360),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
959,GO_Biological_Process_2017b,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),2/733,0.2877486708851342,0.3466501867594094,0,0,1.9496377362314437,2.4286010479160782,PRKN;GLIS3
901,GO_Biological_Process_2017b,positive regulation of invasive growth in response to glucose limitation by positive regulation of transcription from RNA polymerase II promoter (GO:0036095),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
958,GO_Biological_Process_2017b,MAPK cascade involved in osmosensory signaling pathway (GO:0000161),1/232,0.287235431468704,0.3466501867594094,0,0,3.051948051948052,3.807161999825019,FRS3
957,GO_Biological_Process_2017b,ERK5 cascade (GO:0070375),1/232,0.287235431468704,0.3466501867594094,0,0,3.051948051948052,3.807161999825019,FRS3
956,GO_Biological_Process_2017b,MAPK cascade involved in innate immune response (GO:0035420),1/232,0.287235431468704,0.3466501867594094,0,0,3.051948051948052,3.807161999825019,FRS3
955,GO_Biological_Process_2017b,MAPK cascade (GO:0000165),1/232,0.287235431468704,0.3466501867594094,0,0,3.051948051948052,3.807161999825019,FRS3
954,GO_Biological_Process_2017b,positive regulation of sodium ion transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061423),2/731,0.2866619452925599,0.3466501867594094,0,0,1.9551897576588932,2.4429150657355465,PRKN;GLIS3
953,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus (GO:1901244),2/730,0.2861185548270158,0.3466501867594094,0,0,1.957977207977208,2.450112873479233,PRKN;GLIS3
926,GO_Biological_Process_2017b,positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by positive regulation of transcription from RNA polymerase II promoter (GO:1904741),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
927,GO_Biological_Process_2017b,protein ubiquitination (GO:0016567),1/226,0.2809303950843264,0.3466501867594094,0,0,3.1342857142857143,3.9794406688293766,PRKN
928,GO_Biological_Process_2017b,actin ubiquitination (GO:0007014),1/226,0.2809303950843264,0.3466501867594094,0,0,3.1342857142857143,3.9794406688293766,PRKN
929,GO_Biological_Process_2017b,isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276),1/226,0.2809303950843264,0.3466501867594094,0,0,3.1342857142857143,3.9794406688293766,PRKN
930,GO_Biological_Process_2017b,positive regulation of transcription via serum response element binding (GO:0010735),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
931,GO_Biological_Process_2017b,transcriptional activation by promoter-enhancer looping (GO:0071733),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
932,GO_Biological_Process_2017b,positive regulation of terminal gap gene transcription (GO:0007363),2/721,0.2812274029761453,0.3466501867594094,0,0,1.9834131767372376,2.516141441446392,PRKN;GLIS3
952,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1904488),2/729,0.2855751473739668,0.3466501867594094,0,0,1.9607723266595345,2.4573380581926503,PRKN;GLIS3
900,GO_Biological_Process_2017b,positive regulation of oligopeptide transport by positive regulation of transcription from RNA polymerase II promoter (GO:0035951),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
914,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072366),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
898,GO_Biological_Process_2017b,positive regulation of mRNA processing (GO:0050685),1/224,0.2788167749764156,0.3466501867594094,0,0,3.162716207559257,4.039422511049997,PRKN
899,GO_Biological_Process_2017b,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter (GO:0072369),2/720,0.280683890462832,0.3466501867594094,0,0,1.986278757866501,2.523619178231724,PRKN;GLIS3
874,GO_Biological_Process_2017b,DNA damage checkpoint (GO:0000077),1/197,0.2496891151288308,0.3466501867594094,0,0,3.603316326530612,4.999740759307304,MCM9
876,GO_Biological_Process_2017b,proteolysis involved in cellular protein catabolic process (GO:0051603),1/198,0.2507878872325828,0.3466501867594094,0,0,3.584844089920232,4.958369101280273,PRKN
877,GO_Biological_Process_2017b,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome (GO:0071630),1/200,0.252980772589684,0.3466501867594094,0,0,3.548456568557071,4.877147000705543,PRKN
878,GO_Biological_Process_2017b,anaphase-promoting complex-dependent catabolic process (GO:0031145),1/201,0.2540748900660081,0.3466501867594094,0,0,3.530535714285714,4.837279526810303,PRKN
879,GO_Biological_Process_2017b,Notch receptor processing (GO:0007220),1/202,0.2551674602345612,0.3466501867594094,0,0,3.5127931769722816,4.79789672092976,PRKN
880,GO_Biological_Process_2017b,telomere maintenance in response to DNA damage (GO:0043247),1/207,0.2606071751014697,0.3466501867594094,0,0,3.4266643550624134,4.607976331326142,MCM9
881,GO_Biological_Process_2017b,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),1/207,0.2606071751014697,0.3466501867594094,0,0,3.4266643550624134,4.607976331326142,PRKN
882,GO_Biological_Process_2017b,histone H4 acetylation involved in response to DNA damage stimulus (GO:2000776),1/209,0.2627723034817502,0.3466501867594094,0,0,3.3933722527472527,4.535131351227306,MCM9
883,GO_Biological_Process_2017b,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/213,0.2670842108208054,0.3466501867594094,0,0,3.3286725067385445,4.394484397320879,MCM9
884,GO_Biological_Process_2017b,protein K33-linked ubiquitination (GO:1990390),1/214,0.2681583769940699,0.3466501867594094,0,0,3.312877263581489,4.360334561251555,PRKN
885,GO_Biological_Process_2017b,positive regulation of histone gene expression (GO:0036207),1/214,0.2681583769940699,0.3466501867594094,0,0,3.312877263581489,4.360334561251555,PRKN
875,GO_Biological_Process_2017b,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome (GO:0071629),1/198,0.2507878872325828,0.3466501867594094,0,0,3.584844089920232,4.958369101280273,PRKN
887,GO_Biological_Process_2017b,positive regulation of snoRNA processing (GO:1902798),1/214,0.2681583769940699,0.3466501867594094,0,0,3.312877263581489,4.360334561251555,PRKN
888,GO_Biological_Process_2017b,positive regulation of tRNA processing (GO:2000237),1/214,0.2681583769940699,0.3466501867594094,0,0,3.312877263581489,4.360334561251555,PRKN
889,GO_Biological_Process_2017b,positive regulation of production of siRNA involved in RNA interference (GO:1903705),1/215,0.2692310230932951,0.3466501867594094,0,0,3.297229639519359,4.326576745257571,PRKN
890,GO_Biological_Process_2017b,positive regulation of rhodopsin gene expression (GO:0045872),1/215,0.2692310230932951,0.3466501867594094,0,0,3.297229639519359,4.326576745257571,PRKN
891,GO_Biological_Process_2017b,negative regulation of mRNA catabolic process (GO:1902373),1/215,0.2692310230932951,0.3466501867594094,0,0,3.297229639519359,4.326576745257571,PRKN
892,GO_Biological_Process_2017b,negative regulation of gene silencing (GO:0060969),1/216,0.2703021511677209,0.3466501867594094,0,0,3.2817275747508305,4.293204803672334,PRKN
893,GO_Biological_Process_2017b,protein K27-linked ubiquitination (GO:0044314),1/217,0.271371763278782,0.3466501867594094,0,0,3.2663690476190474,4.260212713760186,PRKN
894,GO_Biological_Process_2017b,protein K29-linked ubiquitination (GO:0035519),1/217,0.271371763278782,0.3466501867594094,0,0,3.2663690476190474,4.260212713760186,PRKN
895,GO_Biological_Process_2017b,protein K6-linked ubiquitination (GO:0085020),1/220,0.2745715246289452,0.3466501867594094,0,0,3.221135029354208,4.163457108292861,PRKN
897,GO_Biological_Process_2017b,positive regulation of protein maturation (GO:1903319),1/222,0.2766971569696996,0.3466501867594094,0,0,3.191661279896574,4.100747482803931,PRKN
896,GO_Biological_Process_2017b,positive regulation of rRNA processing (GO:2000234),1/220,0.2745715246289452,0.3466501867594094,0,0,3.221135029354208,4.163457108292861,PRKN
886,GO_Biological_Process_2017b,protein linear polyubiquitination (GO:0097039),1/214,0.2681583769940699,0.3466501867594094,0,0,3.312877263581489,4.360334561251555,PRKN
962,GO_Biological_Process_2017b,histone ubiquitination (GO:0016574),1/235,0.2903678993677779,0.348258492472336,0,0,3.0123626373626373,3.72510734275867,PRKN
963,GO_Biological_Process_2017b,positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter (GO:1900404),2/739,0.2910083296277875,0.348258492472336,0,0,1.9331624704759036,2.386302303244908,PRKN;GLIS3
964,GO_Biological_Process_2017b,sterol regulatory element binding protein cleavage (GO:0035103),1/236,0.2914090984569289,0.348258492472336,0,0,2.9993920972644377,3.698331926770984,PRKN
965,GO_Biological_Process_2017b,protein K11-linked ubiquitination (GO:0070979),1/236,0.2914090984569289,0.348258492472336,0,0,2.9993920972644377,3.698331926770984,PRKN
966,GO_Biological_Process_2017b,protein monoubiquitination (GO:0006513),1/237,0.292448822460311,0.348430603176297,0,0,2.9865314769975786,3.671837695070991,PRKN
967,GO_Biological_Process_2017b,MAPK cascade involved in axon regeneration (GO:1903616),1/237,0.292448822460311,0.348430603176297,0,0,2.9865314769975786,3.671837695070991,FRS3
968,GO_Biological_Process_2017b,protein K63-linked ubiquitination (GO:0070534),1/238,0.2934870733466653,0.3488813246481131,0,0,2.9737793851717904,3.645620631106995,PRKN
969,GO_Biological_Process_2017b,positive regulation of transcription of Notch receptor target (GO:0007221),2/744,0.293723994401689,0.3488813246481131,0,0,1.9196366177498247,2.3517751295535936,PRKN;GLIS3
247,GO_Biological_Process_2018,antigen receptor-mediated signaling pathway (GO:0050851),1/257,0.3129366186556827,0.3495300135791294,0,0,2.7504185267857144,3.1953113898715704,ITK
986,GO_Biological_Process_2017b,regulation of carbohydrate metabolic process by transcription from RNA polymerase II promoter (GO:0100024),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
985,GO_Biological_Process_2017b,positive regulation of purine nucleotide biosynthetic process by transcription from RNA polymerase II promoter (GO:0100036),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
984,GO_Biological_Process_2017b,positive regulation of sulfate assimilation by transcription from RNA polymerase II promoter (GO:0100053),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
983,GO_Biological_Process_2017b,negative regulation of mating type switching by transcription from RNA polymerase II promoter (GO:0100050),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
987,GO_Biological_Process_2017b,regulation of fungal-type cell wall biogenesis by transcription from RNA polymerase II promoter (GO:0100033),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
981,GO_Biological_Process_2017b,regulation of thiamine biosynthetic process by transcription from RNA polymerase II promoter (GO:0100016),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
980,GO_Biological_Process_2017b,negative regulation of cellular amino acid biosynthetic process by transcription from RNA polymerase II promoter (GO:0100025),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
979,GO_Biological_Process_2017b,protein autoubiquitination (GO:0051865),1/253,0.3088854311462448,0.3510514389908,0,0,2.794642857142857,3.283104072481345,PRKN
978,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),2/770,0.3078298996256509,0.3510514389908,0,0,1.852141203703704,2.1822074398121725,PRKN;GLIS3
976,GO_Biological_Process_2017b,signal peptide processing (GO:0006465),1/250,0.3058319149477974,0.3510514389908,0,0,2.828743545611016,3.3512679940063803,PRKN
977,GO_Biological_Process_2017b,stress-activated MAPK cascade (GO:0051403),1/250,0.3058319149477974,0.3510514389908,0,0,2.828743545611016,3.3512679940063803,FRS3
982,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by transcription from RNA polymerase II promoter (GO:0100064),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
988,GO_Biological_Process_2017b,positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by transcription from RNA polymerase II promoter (GO:1904740),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1001,GO_Biological_Process_2017b,positive regulation of flocculation via cell wall protein-carbohydrate interaction by transcription from RNA polymerase II promoter (GO:0100054),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
990,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by transcription from RNA polymerase II promoter (GO:0100049),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1012,GO_Biological_Process_2017b,regulation of phenotypic switching by transcription from RNA polymerase II promoter (GO:0100057),1/259,0.314953604647273,0.3510514389908,0,0,2.7288205980066444,3.152688131866968,GLIS3
1011,GO_Biological_Process_2017b,negative regulation of arginine catabolic process by transcription from RNA polymerase II promoter (GO:0100045),1/259,0.314953604647273,0.3510514389908,0,0,2.7288205980066444,3.152688131866968,GLIS3
1010,GO_Biological_Process_2017b,positive regulation of phospholipid biosynthetic process by transcription from RNA polymerase II promoter (GO:0100032),1/259,0.314953604647273,0.3510514389908,0,0,2.7288205980066444,3.152688131866968,GLIS3
1009,GO_Biological_Process_2017b,positive regulation of arginine biosynthetic process by transcription from RNA polymerase II promoter (GO:0100046),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1008,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by transcription from RNA polymerase II promoter (GO:0100040),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1007,GO_Biological_Process_2017b,positive regulation of pyrimidine-containing compound salvage by transcription from RNA polymerase II promoter (GO:0100068),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1006,GO_Biological_Process_2017b,regulation of transport by transcription from RNA polymerase II promoter (GO:0100020),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1005,GO_Biological_Process_2017b,promoter clearance from RNA polymerase II promoter (GO:0001111),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1004,GO_Biological_Process_2017b,positive regulation of cellular alcohol catabolic process by transcription from RNA polymerase II promoter (GO:0100037),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1003,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by transcription from RNA polymerase II promoter (GO:0100043),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
1002,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by transcription from RNA polymerase II promoter (GO:0100044),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
975,GO_Biological_Process_2017b,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/249,0.3048111846448894,0.3510514389908,0,0,2.8402937788018434,3.374447268365372,PRKN
1000,GO_Biological_Process_2017b,telomeric repeat-containing RNA transcription from RNA pol II promoter (GO:0097394),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
999,GO_Biological_Process_2017b,regulation of meiotic nuclear division by transcription from RNA polymerase II promoter (GO:0100023),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
998,GO_Biological_Process_2017b,positive regulation of peroxisome organization by transcription from RNA polymerase II promoter (GO:0100004),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
997,GO_Biological_Process_2017b,snoRNA transcription from an RNA polymerase II promoter (GO:0001015),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
995,GO_Biological_Process_2017b,positive regulation of mating type switching by transcription from RNA polymerase II promoter (GO:0100014),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
994,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by transcription from RNA polymerase II promoter (GO:0100042),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
993,GO_Biological_Process_2017b,positive regulation of ethanol catabolic process by transcription from RNA polymerase II promoter (GO:0100005),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
992,GO_Biological_Process_2017b,regulation of pyrimidine nucleotide biosynthetic process by transcription from RNA polymerase II promoter (GO:0100039),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
991,GO_Biological_Process_2017b,regulation of conjugation with cellular fusion by transcription from RNA polymerase II promoter (GO:0100028),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
989,GO_Biological_Process_2017b,positive regulation of pseudohyphal growth by transcription from RNA polymerase II promoter (GO:0100041),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
974,GO_Biological_Process_2017b,positive regulation of RNA splicing (GO:0033120),1/248,0.3037890052258202,0.3510514389908,0,0,2.8519375361480623,3.3978607818312265,PRKN
996,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by transcription from RNA polymerase II promoter (GO:0100056),1/258,0.3139458273481307,0.3510514389908,0,0,2.7395775430794886,3.173896009518232,GLIS3
972,GO_Biological_Process_2017b,ERK1 and ERK2 cascade (GO:0070371),1/245,0.3007137525943504,0.3510514389908,0,0,2.8874414519906324,3.4695394120619096,FRS3
971,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to Gram-negative bacterium (GO:1902097),2/756,0.3002381283961128,0.3510514389908,0,0,1.8879064741133704,2.2714900992375666,PRKN;GLIS3
970,GO_Biological_Process_2017b,protein K48-linked ubiquitination (GO:0070936),1/243,0.298656302303171,0.3510514389908,0,0,2.9115997638724918,3.5185572586179696,PRKN
973,GO_Biological_Process_2017b,ubiquitin-dependent ERAD pathway (GO:0030433),1/247,0.3027653747441604,0.3510514389908,0,0,2.863675958188153,3.4215117708694414,PRKN
1013,GO_Biological_Process_2017b,pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/260,0.3159599525934874,0.3516693034588458,0,0,2.718146718146718,3.131685031779052,GLIS3
1015,GO_Biological_Process_2017b,"positive regulation of gene expression, epigenetic (GO:0045815)",1/261,0.3169648730850546,0.3517812714125142,0,0,2.707554945054945,3.1108840309160315,PRKN
1014,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by transcription from RNA polymerase II promoter (GO:0100007),1/261,0.3169648730850546,0.3517812714125142,0,0,2.707554945054945,3.1108840309160315,GLIS3
1016,GO_Biological_Process_2017b,regulation of cAMP-mediated signaling by transcription from RNA polymerase II promoter (GO:0100019),1/262,0.3179683680543941,0.3523922939406249,0,0,2.6970443349753697,3.0902824952732124,GLIS3
248,GO_Biological_Process_2018,regulation of protein phosphorylation (GO:0001932),1/261,0.3169648730850546,0.3526075094159041,0,0,2.707554945054945,3.1108840309160315,PRKN
1017,GO_Biological_Process_2017b,positive regulation of fatty acid beta-oxidation by transcription from RNA polymerase II promoter (GO:0100013),1/265,0.320970319577896,0.3552132412967327,0,0,2.66599025974026,3.029648986692488,GLIS3
1018,GO_Biological_Process_2017b,regulation of fatty acid biosynthetic process by transcription from RNA polymerase II promoter (GO:0100070),1/266,0.3219681320621544,0.355811373216415,0,0,2.6557951482479782,3.009819830976711,GLIS3
1019,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by transcription from RNA polymerase II promoter (GO:0100017),1/268,0.3239595116649867,0.3569978754608494,0,0,2.635634028892456,2.970719933968649,GLIS3
1020,GO_Biological_Process_2017b,apoptotic mitochondrial changes (GO:0008637),1/268,0.3239595116649867,0.3569978754608494,0,0,2.635634028892456,2.970719933968649,PRKN
1021,GO_Biological_Process_2017b,transcription elongation from RNA polymerase II promoter (GO:0006368),1/270,0.3259452437116957,0.3586780758241857,0,0,2.615772703133298,2.9323488854172703,GLIS3
1022,GO_Biological_Process_2017b,cellular protein modification process (GO:0006464),1/271,0.3269359967059965,0.3587534632401485,0,0,2.605952380952381,2.913430932998247,PRKN
1023,GO_Biological_Process_2017b,mRNA transcription from RNA polymerase II promoter (GO:0042789),1/271,0.3269359967059965,0.3587534632401485,0,0,2.605952380952381,2.913430932998247,GLIS3
249,GO_Biological_Process_2018,regulation of programmed cell death (GO:0043067),1/268,0.3239595116649867,0.3589471389248053,0,0,2.635634028892456,2.970719933968649,PRKN
1024,GO_Biological_Process_2017b,tumor necrosis factor-mediated signaling pathway (GO:0033209),1/272,0.3279253435879597,0.3593322779034263,0,0,2.596204533473906,2.8946883708615303,EDAR
1025,GO_Biological_Process_2017b,MAPK import into nucleus (GO:0000189),1/273,0.3289132863351207,0.3599079279447594,0,0,2.586528361344538,2.876119000304039,FRS3
1026,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by transcription from RNA polymerase II promoter (GO:0100052),1/276,0.3318687085749296,0.3626318192012573,0,0,2.5579220779220777,2.821428580633992,GLIS3
1027,GO_Biological_Process_2017b,positive regulation of translation (GO:0045727),1/277,0.3328510537605025,0.3631951189700855,0,0,2.5485248447204967,2.803530686849432,PRKN
1028,GO_Biological_Process_2017b,DNA repair (GO:0006281),1/279,0.3348115622311917,0.364822682655276,0,0,2.5299331963001026,2.768221041975584,MCM9
250,GO_Biological_Process_2018,positive regulation of macromolecule metabolic process (GO:0010604),1/276,0.3318687085749296,0.3662455469133685,0,0,2.5579220779220777,2.821428580633992,PRKN
251,GO_Biological_Process_2018,MAPK cascade (GO:0000165),1/278,0.3338320043456628,0.3669502587450342,0,0,2.539195461578133,2.785795506504904,FRS3
1030,GO_Biological_Process_2017b,positive regulation of DNA repair by transcription from RNA polymerase II promoter (GO:0100026),1/282,0.3377418988200716,0.3669877057011393,0,0,2.5025419420437216,2.7164424305844275,GLIS3
1029,GO_Biological_Process_2017b,positive regulation of gene expression (GO:0010628),1/282,0.3377418988200716,0.3669877057011393,0,0,2.5025419420437216,2.7164424305844275,PRKN
1031,GO_Biological_Process_2017b,snRNA transcription from RNA polymerase II promoter (GO:0042795),1/286,0.3416296319925714,0.3706943566111862,0,0,2.4669172932330827,2.649538434400492,GLIS3
252,GO_Biological_Process_2018,protein polyubiquitination (GO:0000209),1/283,0.3387159049952631,0.370847058038292,0,0,2.4935410334346506,2.6994914676691124,PRKN
254,GO_Biological_Process_2018,proteolysis (GO:0006508),1/291,0.3464583186498783,0.3763488402588874,0,0,2.423768472906404,2.569177033402205,PGC
253,GO_Biological_Process_2018,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/291,0.3464583186498783,0.3763488402588874,0,0,2.423768472906404,2.569177033402205,PRKN
1032,GO_Biological_Process_2017b,protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process (GO:1901044),1/292,0.3474199441751808,0.3764522514878701,0,0,2.4153166421207657,2.5535235167414063,PRKN
255,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),2/848,0.3498531928964941,0.3785520876262846,0,0,1.6745468873128448,1.7586789049551854,PRKN;GLIS3
1034,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress by regulation of transcription from RNA polymerase II promoter (GO:1900427),1/303,0.3579080648517554,0.3867395478537024,0,0,2.326040681173132,2.389958249972061,PRKN
1033,GO_Biological_Process_2017b,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter (GO:0072367),1/303,0.3579080648517554,0.3867395478537024,0,0,2.326040681173132,2.389958249972061,PRKN
314,WikiPathways_2019_Human,PI3K-Akt Signaling Pathway WP4172,1/340,0.3920052604611007,0.3920052604611007,0,0,2.06826801517067,1.9368916716706923,COL6A5
1035,GO_Biological_Process_2017b,protein phosphorylation involved in cellular protein catabolic process (GO:1902002),1/310,0.3644973838196466,0.3933134044544869,0,0,2.2725381414701804,2.2935270878734726,PRKN
1036,GO_Biological_Process_2017b,transcription from RNA polymerase II promoter (GO:0006366),1/314,0.3682333446256914,0.3967943796659112,0,0,2.243039707895938,2.240882920031033,GLIS3
256,GO_Biological_Process_2018,DNA metabolic process (GO:0006259),1/314,0.3682333446256914,0.3968896360362511,0,0,2.243039707895938,2.240882920031033,CDC25A
291,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.34933909843265,0.3983773199361312,0,0,2.398586055582643,2.5226222168269707,EDAR
292,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.354113173276561,0.3983773199361312,0,0,2.3577420901246406,2.447663351806148,CDC25A
1037,GO_Biological_Process_2017b,"negative regulation of transcription, DNA-templated (GO:0045892)",2/895,0.3748379075953104,0.4033525478688126,0,0,1.582514205134586,1.5528604096691974,ATF7IP;PRKN
294,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.4044453761134738,0.4044453761134738,0,0,1.9848239579117768,1.7967392452521151,COL6A5
293,KEGG_2019_Human,Human papillomavirus infection,1/330,0.3829662482812284,0.4044453761134738,0,0,2.1322188449848025,2.0465215970248147,COL6A5
257,GO_Biological_Process_2018,cellular response to DNA damage stimulus (GO:0006974),1/329,0.3820552439283418,0.4101910952253902,0,0,2.1388283972125435,2.0579594307268625,MCM9
1038,GO_Biological_Process_2017b,termination of RNA polymerase II transcription (GO:0006369),1/329,0.3820552439283418,0.4105510770390193,0,0,2.1388283972125435,2.0579594307268625,GLIS3
1039,GO_Biological_Process_2017b,central nervous system development (GO:0007417),1/333,0.3856914876010626,0.4138868653153472,0,0,2.1126290877796903,2.012738669158636,PRKN
258,GO_Biological_Process_2018,ubiquitin-dependent protein catabolic process (GO:0006511),1/341,0.3929020974919137,0.420208034769344,0,0,2.062079831932773,1.926384284930168,PRKN
1040,GO_Biological_Process_2017b,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/344,0.3955849514702657,0.4239188598400368,0,0,2.043731778425656,1.8953358411746248,PRKN
1041,GO_Biological_Process_2017b,translation (GO:0006412),1/348,0.3991442888871087,0.4271447823303584,0,0,2.019761218608481,1.8550139438403408,PRKN
259,GO_Biological_Process_2018,"transcription, DNA-templated (GO:0006351)",1/356,0.4062023489310624,0.4327617332842472,0,0,1.973440643863179,1.777880268191738,GLIS3
1042,GO_Biological_Process_2017b,transcription initiation from RNA polymerase II promoter (GO:0006367),1/355,0.4053244890237336,0.4331627094237153,0,0,1.9791162227602903,1.7872751935578657,GLIS3
260,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),2/1001,0.429824737496821,0.4561741466920285,0,0,1.40674007340674,1.187820004791104,PTPRT;LARGE1
1043,GO_Biological_Process_2017b,protein polyubiquitination (GO:0000209),1/381,0.4277466197583625,0.4564977642963046,0,0,1.8412593984962409,1.5636421660235609,PRKN
1044,GO_Biological_Process_2017b,"positive regulation of transcription, DNA-templated (GO:0045893)",2/1004,0.4313486585421175,0.459711310062695,0,0,1.4023064981148814,1.1791133812796428,ATF7IP;PRKN
1045,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),1/387,0.4328038225003213,0.4606311544531463,0,0,1.8120836417468544,1.5175669911828562,PTPRT
261,GO_Biological_Process_2018,protein modification by small protein conjugation (GO:0032446),1/398,0.4419635095667988,0.4672667639313101,0,0,1.760885210507377,1.437812004950335,PRKN
1047,GO_Biological_Process_2017b,negative regulation of cell proliferation (GO:0008285),1/399,0.4427890899512054,0.4699725947913203,0,0,1.7563711414213927,1.4308483301538075,ITK
1046,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process (GO:0043524),1/399,0.4427890899512054,0.4699725947913203,0,0,1.7563711414213927,1.4308483301538075,PRKN
1048,GO_Biological_Process_2017b,"negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated (GO:0010678)",1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1049,GO_Biological_Process_2017b,chromatin organization involved in negative regulation of transcription (GO:0097549),1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1051,GO_Biological_Process_2017b,negative regulation of antisense RNA transcription (GO:0060195),1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1052,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase V promoter (GO:1904280),1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1053,GO_Biological_Process_2017b,negative regulation of transcription by pheromones (GO:0045996),1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1054,GO_Biological_Process_2017b,negative regulation of ncRNA transcription associated with protein coding gene TSS/TES (GO:1904388),1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1055,GO_Biological_Process_2017b,"negative regulation of mating-type specific transcription, DNA-templated (GO:0045894)",1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1056,GO_Biological_Process_2017b,negative regulation of transcription during mitotic cell cycle (GO:0007068),1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1057,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor catabolism (GO:0010620),1/413,0.4542241202841421,0.4737082648539713,0,0,1.695475034674064,1.3380087855449434,ATF7IP
1058,GO_Biological_Process_2017b,carbon catabolite repression of transcription (GO:0045013),1/413,0.4542241202841421,0.4737082648539713,0,0,1.695475034674064,1.3380087855449434,ATF7IP
1059,GO_Biological_Process_2017b,negative regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090419),1/413,0.4542241202841421,0.4737082648539713,0,0,1.695475034674064,1.3380087855449434,ATF7IP
1060,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080),1/413,0.4542241202841421,0.4737082648539713,0,0,1.695475034674064,1.3380087855449434,PRKN
1050,GO_Biological_Process_2017b,nitrogen catabolite repression of transcription (GO:0090295),1/412,0.4534149036407658,0.4737082648539713,0,0,1.6996871741397288,1.3443636111425554,ATF7IP
1061,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, termination (GO:0060567)",1/414,0.455032180157118,0.4739157110605594,0,0,1.6912832929782082,1.3316947097653555,ATF7IP
1062,GO_Biological_Process_2017b,negative regulation of transcription by competitive promoter binding (GO:0010944),1/416,0.4566448358309066,0.4749594682840178,0,0,1.682960413080895,1.3191874338137728,ATF7IP
1063,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),1/419,0.4590551832279232,0.4768290154223288,0,0,1.6706254272043746,1.3007236497353705,ATF7IP
1064,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/422,0.4614552052870138,0.4786828662843957,0,0,1.658466236851035,1.2826085196074395,ATF7IP
1065,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase III promoter (GO:0016480),1/423,0.4622529255151771,0.478871872238093,0,0,1.6544515910629656,1.2766461212330855,ATF7IP
1066,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, initiation (GO:2000143)",1/424,0.4630495047872914,0.479059195112384,0,0,1.6504559270516717,1.27072118751331,ATF7IP
1067,GO_Biological_Process_2017b,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),1/430,0.4678051087893121,0.4833364869031671,0,0,1.626873126873127,1.2359412150622389,ATF7IP
1068,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor localization (GO:0010621),1/432,0.4693812537016256,0.4843217710608285,0,0,1.6191581040768976,1.2246339320947628,ATF7IP
1069,GO_Biological_Process_2017b,positive regulation of cell proliferation (GO:0008284),1/442,0.4771946150675321,0.4917316695662781,0,0,1.5816326530612246,1.1701406668864285,ITK
262,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),1/444,0.4787439013425913,0.5042283675737559,0,0,1.5743308610125766,1.159635545976525,ATF7IP
1074,GO_Biological_Process_2017b,positive regulation of transcription by pheromones (GO:0009371),1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1080,GO_Biological_Process_2017b,carbon catabolite activation of transcription (GO:0045991),1/470,0.4984856112020138,0.5062947852678418,0,0,1.4850746268656716,1.0338800767379608,ATF7IP
1079,GO_Biological_Process_2017b,DNA damage induced protein phosphorylation (GO:0006975),1/470,0.4984856112020138,0.5062947852678418,0,0,1.4850746268656716,1.0338800767379608,MCM9
1078,GO_Biological_Process_2017b,positive regulation of transcription from mitochondrial promoter (GO:1903109),1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1077,GO_Biological_Process_2017b,nitrogen catabolite activation of transcription (GO:0090294),1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1076,GO_Biological_Process_2017b,positive regulation of transcription during mitotic cell cycle (GO:0045897),1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1075,GO_Biological_Process_2017b,positive regulation of chromatin-mediated maintenance of transcription (GO:1904501),1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1073,GO_Biological_Process_2017b,positive regulation of antisense RNA transcription (GO:0060196),1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1072,GO_Biological_Process_2017b,"positive regulation of mating-type specific transcription, DNA-templated (GO:0045895)",1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1071,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase V promoter (GO:1904281),1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1070,GO_Biological_Process_2017b,positive regulation of transcription from a mobile element promoter (GO:0061435),1/469,0.4977398474770508,0.5062947852678418,0,0,1.488324175824176,1.0383706370734351,ATF7IP
1081,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, termination (GO:0060566)",1/472,0.4999739324884341,0.5071443539452435,0,0,1.478616924476797,1.0249762420664252,ATF7IP
263,GO_Biological_Process_2018,nervous system development (GO:0007399),1/455,0.4871860572418413,0.511176279757538,0,0,1.5353209565764632,1.1040633958656791,PRKN
1082,GO_Biological_Process_2017b,positive regulation of transcription involved in exit from mitosis (GO:0007072),1/481,0.5066187693610981,0.5132153679204873,0,0,1.4502232142857143,0.9861466989610632,ATF7IP
1083,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/482,0.5073517999094491,0.513289597307609,0,0,1.447133947133947,0.9819536523834056,ATF7IP
1084,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase III promoter (GO:0045945),1/485,0.5095445876667556,0.5148385574087478,0,0,1.4379427390791026,0.9695155179587908,ATF7IP
1085,GO_Biological_Process_2017b,positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931),1/487,0.5110012076580698,0.515640647935121,0,0,1.431878306878307,0.961339219323404,ATF7IP
1086,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/488,0.5117279503849494,0.5157051106211019,0,0,1.4288647697271928,0.9572853018430938,ATF7IP
1087,GO_Biological_Process_2017b,positive regulation of transcription by transcription factor localization (GO:0061586),1/490,0.5131783086690709,0.5164977026449381,0,0,1.422874671340929,0.9492451028051972,ATF7IP
1088,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/493,0.5153460496918498,0.5180093367703607,0,0,1.4139808362369335,0.9373514572504053,ATF7IP
264,GO_Biological_Process_2018,cellular protein metabolic process (GO:0044267),1/484,0.5088147075488486,0.5286286546205667,0,0,1.4409937888198758,0.9736382345248163,PRKN
266,GO_Biological_Process_2018,negative regulation of apoptotic process (GO:0043066),1/485,0.5095445876667556,0.5286286546205667,0,0,1.4379427390791026,0.9695155179587908,PRKN
265,GO_Biological_Process_2018,transcription from RNA polymerase II promoter (GO:0006366),1/485,0.5095445876667556,0.5286286546205667,0,0,1.4379427390791026,0.9695155179587908,GLIS3
1089,GO_Biological_Process_2017b,negative regulation of chromatin silencing (GO:0031936),1/509,0.526750850006456,0.5287898855548682,0,0,1.3683211473565804,0.8771316383849315,ATF7IP
267,GO_Biological_Process_2018,positive regulation of nucleic acid-templated transcription (GO:1903508),1/502,0.5217934999393405,0.5393164159820796,0,0,1.3879384088964928,0.902830844346328,ATF7IP
268,GO_Biological_Process_2018,protein ubiquitination (GO:0016567),1/506,0.5246323774572892,0.5402348273444949,0,0,1.3766619519094767,0.8880261102749738,PRKN
269,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/512,0.5288602057300218,0.5425713962489482,0,0,1.360078277886497,0.8664122205121919,ATF7IP
270,GO_Biological_Process_2018,negative regulation of cellular process (GO:0048523),1/534,0.5440538184873507,0.5560992904833806,0,0,1.3024658268560707,0.7928202040990084,PRKN
1090,GO_Biological_Process_2017b,chromatin-mediated maintenance of transcription (GO:0048096),1/554,0.5574548345097085,0.5588915737739087,0,0,1.2540687160940325,0.732844892635155,ATF7IP
1091,GO_Biological_Process_2017b,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/557,0.5594318946670258,0.5601518842354518,0,0,1.2471094552929085,0.7243629298329822,CDC25A
1092,GO_Biological_Process_2017b,regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117),1/583,0.5762129086975999,0.5762129086975999,0,0,1.18980117820324,0.6559112774864561,CDC25A
271,GO_Biological_Process_2018,cytokine-mediated signaling pathway (GO:0019221),1/633,0.6067662454094457,0.6179200366853546,0,0,1.0928458408679929,0.5459985249689162,EDAR
272,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),2/1478,0.6425609637969211,0.6519757764532862,0,0,0.9281842818428184,0.4105299502405541,PRKN;GLIS3
273,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),1/740,0.6651699857852758,0.6724528688413189,0,0,0.929441329982602,0.3789449907048028,ITK
274,GO_Biological_Process_2018,regulation of apoptotic process (GO:0042981),1/815,0.7010153694661975,0.7061136630623153,0,0,0.8405142155142156,0.2985720548347098,PRKN
275,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),1/1037,0.786718103924139,0.7895685318369077,0,0,0.6527509652509652,0.1565853516099803,PRKN
276,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",1/1598,0.9107811835967168,0.9107811835967168,0,0,0.4109043742731908,0.0384000838572188,ATF7IP
